Mosaic ImmunoEngineering Inc. - Quarter Report: 2007 February (Form 10-Q)

Patriot Scientific Corporation

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 28, 2007

[_]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ____________

Commission File Number 0-22182

PATRIOT SCIENTIFIC CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction of

incorporation or organization)

84-1070278

(I.R.S. Employer Identification No.)

6183 Paseo Del Norte, Suite 180, Carlsbad, California

(Address of principal executive offices)

92011

(Zip Code)

(Issuer’s telephone number): (760) 547-2700

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES [X ] NO [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer [ ]

Accelerated filer [ ]

Non-accelerated filer [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [ ] No [X]

On April 18, 2007, 390,092,696 shares of common stock, par value $0.00001 per share (the issuer’s only class of voting stock) were outstanding.

INDEX

	Page
PART I. FINANCIAL INFORMATION
ITEM 1. Financial Statements
Condensed Consolidated Balance Sheets as of February 28, 2007 (unaudited) and May 31, 2006	3
Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended February 28, 2007 and 2006	4
Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended February 28, 2007 and 2006	5-6
Notes to Unaudited Condensed Consolidated Financial Statements	7-27
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	28-37
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk	37
ITEM 4. Controls and Procedures	37
PART II. OTHER INFORMATION
ITEM 1. Legal Proceedings	38-39
ITEM 1A. Risk Factors	39-41
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds	41-42
ITEM 3. Defaults Upon Senior Securities	42
ITEM 4. Submission of Matters to a Vote of Security Holders	42
ITEM 5. Other Information	42
ITEM 6. Exhibits	42-49

SIGNATURES

PART I- FINANCIAL INFORMATION

Item 1. Financial Statements

Patriot Scientific Corporation

Condensed Consolidated Balance Sheets

	February 28, 2007			May 31, 2006
ASSETS	(Unaudited)

Current assets:
Cash and cash equivalents	$	15,388,002		$	3,984,240
Restricted cash and cash equivalents		102,220			100,320
Marketable securities and short term investments		3,614,992			3,518,879
Accounts receivable		16,786			4,113
Prepaid income taxes		1,081,627			-
Deferred tax assets		2,380,925			-
Prepaid expenses and other current assets		171,778			407,418

Total current assets		22,756,330			8,014,970

Property and equipment, net		54,281			64,006

Other assets		8,190			8,190

Investments in affiliated companies		5,304,628			3,952,914

Patents and trademarks, net of accumulated amortization of $601,304 and $584,387		14,670			31,587
	$	28,138,099		$	12,071,667

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:
Accounts payable	$	348,423		$	695,323
Accrued expenses and other		376,533			154,730
Accrued contingency fee payable		-			394,063
Accrued settlement fee payable		3,000,000			-

Total current liabilities		3,724,956			1,244,116

Deferred tax liabilities		4,828,063			-

Total liabilities		8,553,019			1,244,116

Commitments and contingencies

Stockholders’ equity:
Preferred stock, $0.00001 par value; 5,000,000 shares authorized: none outstanding		-			-
Common stock, $0.00001 par value: 500,000,000 shares authorized: 389,447,145 shares issued and 378,668,118 shares outstanding at February 28, 2007 and 366,199,765 shares issued and outstanding at May 31, 2006		3,894			3,661
Additional paid-in capital		72,025,107			69,551,981
Accumulated deficit		(45,002,257	)		(58,728,091	)
Common stock held in treasury, at cost -10,779,027 shares and no shares as of February 28, 2007 and May 31, 2006, respectively		(7,441,664	)		-
Total stockholders’ equity		19,585,080			10,827,551

	$	28,138,099		$	12,071,667

See accompanying notes to unaudited condensed consolidated financial statements.

Patriot Scientific Corporation

Condensed Consolidated Statements of Operations

(Unaudited)

	Three Months Ended						Nine Months Ended
	February 28, 2007			February 28, 2006			February 28, 2007			February 28, 2006
				(As restated, see Note 2)						(As restated, see Note 2)
Revenues:
Licenses and royalties	$	-		$	-		$	-		$	10,000,000
Other		22,175			276,800			67,050			297,072
		22,175			276,800			67,050			10,297,072

Cost of goods sold		-			103,351			-			103,351

Gross profit		22,175			173,449			67,050			10,193,721

Operating expenses:
Research and development		-			27,304			-			225,564
Selling, general and administrative		1,445,857			697,455			5,914,803			2,517,189
Settlement and license expense		304,337			-			6,604,337			1,918,054
Total operating expenses		1,750,194			724,759			12,519,140			4,660,807
Operating income (loss)		(1,728,019	)		(551,310	)		(12,452,090	)		5,532,914

Other income (expense):
Unrealized loss on marketable securities		-			(64	)		-			(1,201	)
Interest and other income		191,437			78,089			499,335			171,737
Loss on extinguishment of debt		-			(445,427	)		-			(445,427	)
Loss on sale of assets		-			-			(543	)		-
Interest expense		-			(202,810	)		-			(516,324	)
Change in fair value of warrant and derivative liabilities		-			(4,717,891	)		-			(2,456,736	)
Equity in earnings of affiliated company		11,656,603			29,327,829			30,401,594			28,607,664
Impairment of note receivable		(339,551	)		-			(339,551	)		-
Total other income, net		11,508,489			24,039,726			30,560,835			25,359,713

Income before income taxes		9,780,470			23,488,416			18,108,745			30,892,627

Provision for income taxes		162,911			-			4,382,911			-

Net income	$	9,617,559		$	23,488,416		$	13,725,834		$	30,892,627

Basic income per common share	$	0.03		$	0.08		$	0.04		$	0.10

Diluted income per common share	$	0.02		$	0.06		$	0.03		$	0.08

Weighted average number of common shares outstanding-basic		381,031,577			307,933,709			374,711,954			300,839,387

Weighted average number of common shares outstanding-diluted		410,747,949			404,508,397			416,327,140			397,730,530

See accompanying notes to unaudited condensed consolidated financial statements.

Patriot Scientific Corporation

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Nine months ended
	February 28, 2007			February 28, 2006
				(As restated, see Note 2)
Operating activities:
Net income	$	13,725,834		$	30,892,627
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Amortization and depreciation		31,927			44,584
Non-cash interest expense related to convertible debentures, notes payable and warrants		-			412,879
Expense related to extension of expiration date of stock options		324			125,000
Net gain related to warrant re-pricing, reconveyance and issuance		-			(538,208	)
Loss on extinguishment of debt		-			445,427
Non-cash compensation relating to issuance and vesting of stock options and vesting of warrants		2,359,035			-
Accrued interest income added to investments		(1,900	)		(19,469	)
Equity in earnings of affiliated company		(30,401,594	)		(28,607,664	)
Impairment of note receivable		339,551			-
Unrealized loss on marketable securities		-			1,201
Loss on disposal of fixed assets		543			-
Issuance of stock		-			207,869
Change in fair value of warrant and derivative liabilities		-			2,456,736
Deferred taxes		2,447,138			-
Changes in operating assets and liabilities:
Accounts receivable		(12,673	)		(27,496	)
Prepaid expenses and other assets		235,640			34,266
Prepaid income taxes		(1,081,627	)		-
Licenses receivable		-			1,500,000
Accounts payable and accrued expenses		(125,097	)		48,321
Accrued contested fee payable		(394,063	)		-
Accrued settlement fee payable		3,000,000			-
Net cash provided by (used in) operating activities		(9,876,962	)		6,976,073

Investing activities:
Purchases of marketable securities		(7,537,777	)		(4,327,786	)
Proceeds from sales of marketable securities		7,441,664			862,209
Purchases of property and equipment		(5,828	)		(56,126	)
Purchases of restricted investments		-			(50,000	)
Payment for security deposit		-			(8,190	)
Proceeds from sale of restricted investments		-			203,210
Investment in affiliated company		(120,000	)		(2,000,000	)
Issuance of note receivable		(589,551	)		-
Distributions from affiliated company		29,419,880			10,115,574
Net cash provided by investing activities		28,608,388			4,738,891

Financing activities:
Principal payments on secured notes payable		-			(100,000	)
Payments on capital lease obligations		-			(2,306	)
Proceeds from exercise of common stock warrants and options		114,000			678,994
Repurchase of warrants		-			(252,420	)
Repurchase of common stock for treasury		(7,441,664	)		-
Net cash provided by (used in) financing activities		(7,327,664	)		324,268

Net increase in cash and cash equivalents		11,403,762			12,039,232
Cash and cash equivalents, beginning of period		3,984,240			591,426
Cash and cash equivalents, end of period	$	15,388,002		$	12,630,658

Supplemental Disclosure of Cash Flow Information:
Cash payments for interest	$	-		$	2,843
Cash payments for income taxes	$	3,017,400		$	-

Patriot Scientific Corporation

Condensed Consolidated Statements of Cash Flows, continued

(Unaudited)

	Nine months ended
	February 28, 2007		February 28, 2006

Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Dividend declared but not paid	$	-	$	8,114,378
Convertible debentures, notes payable and accrued interest exchanged for common stock	$	-	$	999,037
Reclassification of derivative liabilities associated with debt conversions and warrant exercises	$	-	$	5,021,353
Reclassification of warrant and derivative liabilities at settlement date	$	-	$	6,743,935
Cashless exercise of warrants	$	225	$	260
Fair market value of assets received in collection of note receivable and subsequently contributed for preferred stock of affiliate	$	250,000	$	-

See accompanying notes to unaudited condensed consolidated financial statements

Patriot ScientificCorporation

Notes to Unaudited Condensed Consolidated Financial Statements

1. Basis of Presentation and Summary of Significant Accounting Policies

The unaudited condensed consolidated financial statements of Patriot Scientific Corporation (the “Company”, “we”, “us” or “our”) presented herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for quarterly reports on Form 10-Q and do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. These financial statements should be read in conjunction with our audited consolidated financial statements and notes thereto included the Company’s annual report on Form 10-KSB for the fiscal year ended May 31, 2006.

In the opinion of management, the interim condensed consolidated financial statements reflect all adjustments of a normal recurring nature necessary for a fair presentation of the results for the interim periods. Operating results for the nine month period ended February 28, 2007 are not necessarily indicative of the results that may be expected for the year ending May 31, 2007.

Reclassifications

Certain reclassifications have been made to the 2006 financial statements in order for them to conform to the 2007 presentation. Such reclassifications have no impact on the Company’s financial position or results of operations.

Investments in Affiliated Companies

The Company has a 50% interest in Phoenix Digital Solutions, LLC (“Phoenix Digital”) (see Note 5). This investment is accounted for using the equity method of accounting since the investment provides the Company the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if the Company has an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee’s Board of Directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize the Company’s share of net earnings or losses of the investee and is recognized in the condensed consolidated statement of operations in the caption “Equity in earnings of affiliated company.”

The Company owns 100% of the preferred stock of Scripps Secured Data, Inc. (“SSDI”) (see Note 5). This investment is accounted for at cost since the Company does not have the ability to exercise significant influence over the operating and financial policies of SSDI.

Derivative Financial Instruments

In connection with the issuance of certain convertible debentures (see Note 6), the terms of the debentures included an embedded reset conversion feature which provided for a conversion of the debentures into shares of the Company's common stock at a rate which was determined to be variable. The Company determined that the reset conversion feature was an embedded derivative instrument and that the conversion option was an embedded put option pursuant to Statement of Financial Accounting Standards (“SFAS”) No. 133, Accounting for Derivative Instruments and Hedging Activities, as amended, and Emerging Issues Task Force (“EITF”) Issue No. 00-19, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company's Own Stock. The accounting treatment of derivative financial instruments required that the Company record the derivatives and related warrants at their fair values as of the inception date of the convertible debenture agreements and at fair value as of each subsequent balance sheet date. In addition, under the provisions of EITF Issue No. 00-19, as a result of entering into the convertible debenture agreements, the Company was required to classify all other non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was recorded as non-operating, non-cash income or expense at each balance sheet date. If the fair value of the derivatives was higher at the subsequent balance sheet date, the Company recorded a non-operating, non-cash charge. If the fair value of the derivatives was lower at the subsequent balance sheet date, the Company recorded non-operating, non-cash income.

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Derivative Financial Instruments, continued

During the three month periods ended February 28, 2007 and 2006, the Company recognized other expense of $0 and $4,717,891, respectively, related to recording the warrant and derivative liabilities at fair value. During the nine month periods ended February 28, 2007 and 2006, the Company recognized other expense of $0 and $2,456,736, respectively, related to recording the warrant and derivative liabilities at fair value. At February 28, 2007, there are no derivative liabilities since the related variable debt instruments were settled in full during fiscal 2006. At the settlement date, the remaining warrant liabilities with a value of approximately $6,744,000 were reclassified to additional paid-in capital.

The Company’s derivative instruments were valued using a Monte Carlo simulation model incorporating the instruments’ multiple reset dates. The following assumptions were used for valuing the embedded derivatives during the nine month period ended February 28, 2006:

Estimated dividends			None

Expected volatility			101 - 229%

Risk-free interest rate			3.5 - 5.1%

Expected term (years)			2 - 7

Revenue Recognition

The Company recognizes revenue from the sale of its product upon shipment to the customer, at which time title transfers and the Company has no further obligations. Fees for maintenance or support are recorded on a straight-line basis over the underlying period of performance. Revenue from technology license agreements is recognized at the time the Company enters into a contract and provides the customer with the licensed technology. At this point, the Company has performed all of its obligations under contract, the rights to the Company’s technology have been transferred and no significant performance obligations remain.

Net Income Per Share

The Company applies SFAS No. 128, Earnings Per Share, for the calculation of "Basic" and "Diluted" earnings per share. Basic earnings per share includes no dilution and is computed by dividing income available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution of securities that could share in the earnings of an entity. For the three and nine months ended February 28, 2007, shares of 3,495,000 and 330,000, respectively, related to the Company’s outstanding warrants and options were not included in the calculation of diluted income per share as they had an anti-dilutive effect. For the three and nine months ended February 28, 2006, 375,000 and 1,925,000 potentially dilutive common shares, respectively, related to the Company’s outstanding warrants and options were not included in the calculation of diluted income per share as they had an anti-dilutive effect.

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Net Income Per Share, continued

	Three Months Ended February 28, 2007
	Numerator (Income)		Denominator (Shares)		Per Share Amount
Basic EPS:
Net income	$	9,617,559		381,031,577	$	0.03
Diluted EPS:
Effect of dilutive securities:
Options and warrants		-		29,716,372
Income available to common stockholders	$	9,617,559		410,747,949	$	0.02

	Three Months Ended February 28, 2006 As restated (See Note 2)
	Numerator (Income)		Denominator (Shares)		Per Share Amount
Basic EPS:
Net income	$	23,488,416		307,933,709	$	0.08
Diluted EPS:
Convertible debentures interest		12,640
Effect of dilutive securities:
Convertible debentures		-		20,557,895
Options and warrants		-		76,016,793
Income available to common stockholders	$	23,501,056		404,508,397	$	0.06

	Nine Months Ended February 28, 2007
	Numerator (Income)		Denominator (Shares)		Per Share Amount
Basic EPS:
Net income	$	13,725,834		374,711,954	$	0.04
Diluted EPS:
Effect of dilutive securities:
Options and warrants		-		41,615,186
Income available to common stockholders	$	13,725,834		416,327,140	$	0.03

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Net Income Per Share, continued

	Nine Months Ended February 28, 2006 As restated (See Note 2)
	Numerator (Income)		Denominator (Shares)		Per Share Amount
Basic EPS:
Net income	$	30,892,627		300,839,387	$	0.10
Diluted EPS:
Convertible debentures interest		42,716
Effect of dilutive securities:
Convertible debentures		-		22,179,305
Options and warrants		-		74,711,838
Income available to common stockholders	$	30,935,343		397,730,530	$	0.08

Stock-Based Compensation

Change in Accounting Principle

Effective June 1, 2006, the Company adopted SFAS No. 123(R), Share-Based Payment, which establishes standards for the accounting of transactions in which an entity exchanges its equity instruments for goods or services, primarily focusing on accounting for transactions where an entity obtains employee services in share-based payment transactions. SFAS No. 123(R) requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period. SFAS No. 123(R) supersedes the Company’s previous accounting under Accounting Principles Board Opinion (“APB”) No. 25, Accounting for Stock Issued to Employees, for the period beginning June 1, 2006. In March 2005, the SEC issued Staff Accounting Bulletin (“SAB”) No. 107, Share-Based Payment, relating to SFAS No. 123(R). The Company has applied the provisions of SAB No. 107 in its adoption of SFAS No. 123(R). Stock-based awards to non-employees are accounted for using the fair value method in accordance with SFAS No. 123, Accounting for Stock Based Compensation.

The Company adopted SFAS No. 123(R) using the modified prospective transition method, which requires the application of the accounting standard as of June 1, 2006, the first day of the Company’s fiscal year 2007. The Company’s condensed consolidated financial statements as of and for the nine months ended February 28, 2007 reflect the impact of adopting SFAS No. 123(R). In accordance with the modified prospective transition method, the Company’s condensed consolidated financial statements for prior periods have not been restated to reflect, and do not include, the impact of SFAS No. 123(R). SFAS No. 123(R) requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the Company’s condensed consolidated statement of operations. Prior to the adoption of SFAS No. 123(R), the Company accounted for stock-based awards to employees and directors using the intrinsic value method in accordance with APB No. 25 as allowed under SFAS No. 123. Under the intrinsic value method, no employee stock-based compensation expense had been recognized in the

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Stock-Based Compensation, continued

Company’s condensed consolidated statements of operations, other than as related to option grants to employees and directors below the fair market value of the underlying stock at the date of grant.

Stock-based compensation expense recognized during the period is based on the value of the portion of share-based payment awards that is ultimately expected to vest during the period. Stock-based compensation expense recognized in the Company’s condensed consolidated statement of operations for the nine months ended February 28, 2007 included compensation expense for share-based payment awards granted prior to, but not yet vested as of May 31, 2006 based on the grant date fair value estimated in accordance with the pro forma provisions of SFAS No. 123 and compensation expense for the share-based payment awards granted subsequent to May 31, 2006 based on the grant date fair value estimated in accordance with the provisions of SFAS No. 123(R). As stock-based compensation expense recognized in the condensed consolidated statement of operations for the nine months ended February 28, 2007 is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures. SFAS No. 123(R) requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The estimated average forfeiture rate for the nine months ended February 28, 2007, of approximately 5% was based on historical forfeiture experience and estimated future employee forfeitures. The estimated pricing term of option grants for the nine months ended February 28, 2007 was five years. In the Company’s pro forma information required under SFAS No. 123 for the periods prior to fiscal 2007, the Company accounted for forfeitures as they occurred.

Summary of Assumptions and Activity

The following table illustrates the effect on net income and net income per share for the three and nine months ended February 28, 2006 as if the Company had applied the fair value recognition provisions of SFAS No. 123 to options granted under the Company's stock option plans. For purposes of this pro forma disclosure, the fair value of the options is estimated using the Black-Scholes option-pricing model and amortized on a straight-line basis to expense over the options' vesting period:

	Three Months Ended		Nine Months Ended
	February 28, 2006 (Unaudited)		February 28, 2006 (Unaudited)
	(As restated see Note 2)		(As restated see Note 2)

Net income - as reported	$	23,488,416	$	30,892,627

Add: Share-based employee compensation included in net income, net of tax effects		-		-

Deduct: Share-based employee compensation expense determined under fair value method, net of tax effects		28,028		210,278

Net income - pro forma	$	23,460,388	$	30,682,349

Net income per common share - as reported
Basic	$	0.08	$	0.10
Diluted	$	0.06	$	0.08

Net income per common share - pro forma
Basic	$	0.08	$	0.10
Diluted	$	0.06	$	0.08

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Stock-Based Compensation, continued

The fair value of stock-based awards to employees and directors is calculated using the Black-Scholes option pricing model, even though this model was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, which differ significantly from the Company’s stock options. The Black-Scholes model also requires subjective assumptions, including future stock price volatility and expected time to exercise, which greatly affect the calculated values. The expected term of options granted is derived from historical data on employee exercises and post-vesting employment termination behavior. The risk-free rate selected to value any particular grant is based on the U.S. Treasury rate that corresponds to the pricing term of the grant effective as of the date of the grant. The expected volatility for the three and nine months ended February 28, 2007 and 2006 is based on the historical volatilities of the Company’s common stock. These factors could change in the future, affecting the determination of stock-based compensation expense in future periods.

	Three Months Ended		Nine Months Ended		Three Months Ended		Nine Months Ended
	February 28, 2007 (Unaudited)		February 28, 2007 (Unaudited)		February 28, 2006 (Unaudited)		February 28, 2006 (Unaudited)

Expected term		5 years		5 years		5 yrs		5 years
Expected volatility		146%		146 - 156%		115%		115 - 128%
Risk-free interest rate		4.78%		4.78 - 5.00%		4.59%		3.72 - 4.59%
Expected dividends		-		-		-		-

A summary of option activity as of February 28, 2007 and changes during the nine months then ended, is presented below:

	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value

Options outstanding at June 1, 2006		5,460,000		$	0.34
Options granted		2,800,000		$	0.39
Options exercised		(515,000	)	$	0.08
Options expired		(500,000	)	$	0.09

Options outstanding and exercisable at February 28, 2007		7,245,000		$	0.40		3.21	$	2,085,200

The aggregate intrinsic value set forth in the above table represents the total pre-tax intrinsic value, based on the Company’s closing stock price of $0.67 as of February 28, 2007, and assumes all optionees had exercised their options as of that date.

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Stock-Based Compensation, continued

The weighted average grant date fair value of options granted during the nine months ended February 28, 2007 was $0.91 per option. The total intrinsic value of options exercised during the nine months ended February 28, 2007 was $290,100.

As of February 28, 2007, there was no unrecognized compensation cost related to employee and director stock option compensation arrangements. The total fair value of shares vested during the nine months ended February 28, 2007 was approximately $2,356,000.

As a result of adopting SFAS No. 123(R) on June 1, 2006, the Company’s income before provision for income taxes and net income for the three months ended February 28, 2007 was approximately $586,000 and $352,000 lower, respectively, than if it had continued to account for share-based compensation under APB No. 25. The Company’s income before income taxes and net income for the nine months ended February 28, 2007 was approximately $886,000 and $532,000 lower than if it had continued to account for share-based compensation under APB No. 25. Basic and diluted net income per share for the three and nine months ended February 28, 2007 were not affected by the adoption of SFAS No. 123(R).

The following table summarizes employee stock-based compensation expense related to stock options under SFAS No. 123(R) for the three and nine months ended February 28, 2007, which was allocated as follows:

	Three Months Ended		Nine Months Ended
	February 28, 2007		February 28, 2007
Employee stock-based compensation expense included in:
Selling, general and administrative	$	586,000	$	2,356,000

Recent Accounting Pronouncements

In July 2006, the Financial Accounting Standards Board issued Interpretation No. 48, Accounting for Uncertainty in Income Taxes - an interpretation of FASB Statement No. 109 (“FIN 48”). This interpretation clarifies the application of SFAS No. 109, Accounting for Income Taxes, by defining criteria that an individual tax position must meet for any part of the benefit of that position to be recognized in a company’s financial statements and also provides guidance on measurement, derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. FIN 48 is effective for fiscal years beginning after December 15, 2006. The Company expects to adopt FIN 48 on June 1, 2007. The Company is currently assessing the impact the adoption of FIN 48 will have on its condensed consolidated financial position and results of operations.

In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements (“SFAS No. 157”). SFAS No. 157 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principals and expands disclosures about fair value measurements. The statement does not require new fair value measurements, but is applied to the extent that other accounting pronouncements require or permit fair value measurements. The statement emphasizes that fair value is a market-based measurement that should be determined based on the assumptions that market participants would use in pricing an asset or liability. Companies that have assets and liabilities measured at fair value will be required to disclose information that enables the users of its financial statements to access the inputs used to develop those measurements. The reporting entity is encouraged, but not required, to combine the fair value information disclosed under this statement with the fair value information disclosed under other accounting pronouncements. SFAS No. 157 is effective for fiscal years beginning after November 15, 2007. The Company expects to adopt SFAS No. 157 on June 1, 2008. The Company is in the process of evaluating the provisions of the statement, but does not anticipate that the adoption of SFAS No. 157 will have a material impact on the Company’s consolidated financial statements.

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Recent Accounting Pronouncements , continued

In September 2006, the SEC staff issued SAB No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements . SAB No. 108 was issued in order to eliminate the diversity in practice surrounding how public companies quantify financial statement misstatements. SAB No. 108 requires that registrants quantify errors using both a balance sheet and income statement approach and evaluate whether either approach results in a misstated amount that, when all relevant quantitative and qualitative factors are considered, is material. The adoption of this statement is not expected to have a material impact on the Company’s consolidated financial condition or results of operations.

2. Restatement of Previously Issued Financial Statements

During fiscal 2006, the Company determined that the manner in which it historically accounted for the reset conversion feature and embedded put option of its convertible debentures issued during fiscal 2002 through fiscal 2005 was not in accordance with SFAS No. 133, as amended, and EITF Issue No. 00-19. The Company determined that the reset conversion feature was an embedded derivative instrument and that the conversion option was an embedded put option pursuant to SFAS No. 133. The accounting treatment of derivative financial instruments required that the Company record the derivatives and related warrants at their fair values as of the inception date of the convertible debenture agreements and at fair value as of each subsequent balance sheet date. In addition, under the provisions of EITF Issue No. 00-19, as a result of entering into the convertible debenture agreements, the Company was required to classify all other non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was required to be recorded as non-operating, non-cash income or expense at each balance sheet date. If the fair value of the derivatives was higher at the subsequent balance sheet date, the Company was required to record a non-operating, non-cash charge. If the fair value of the derivatives was lower at the subsequent balance sheet date, the Company was required to record non-operating, non-cash income. Accordingly, in connection with the restatement adjustments, the Company has appropriately reflected the non-operating, non-cash income or expense resulting from the changes in fair value. The Company had previously not recorded the embedded derivative instruments as liabilities and did not record the related changes in fair value.

In addition, the Company determined the manner in which it accounted for its interest in Phoenix Digital was not in accordance with appropriate accounting literature. Beginning in June 2005, the Company accounted for its interest in Phoenix Digital as a variable interest entity, as defined in FASB Interpretation 46(R). Accordingly, the accounts and transactions of Phoenix Digital were consolidated with those of the Company and the ownership interest of the other member of Phoenix Digital was presented as a minority interest in the condensed consolidated financial statements of the Company for the six month period ended November 30, 2005. The Company has reassessed its accounting for its interest in Phoenix Digital and after further consideration of FIN 46(R) and other authoritative literature, has corrected its accounting policy to account for its interest in Phoenix Digital in accordance with the equity method of accounting for investments, as the Company did not have a controlling financial interest in Phoenix Digital and determined that it was not the primary beneficiary of the relationship.

The following tables present a summary of the effects of the restatement adjustments on the Company's condensed consolidated statements of operations and cash flows for the three and nine month periods ended February 28, 2006:

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Restatement of Previously Issued Financial Statements, continued

	Condensed Consolidated Statement of Operations
Three months ended February 28, 2006	As Previously Reported			Adjustments			As Restated
Revenue - licenses and royalties	$	60,000,000		$	(60,000,000	)	$	-
Total revenue	$	60,276,800		$	(60,000,000	)	$	276,800
Gross profit	$	60,173,449		$	(60,000,000	)	$	173,449
Selling , general and administrative expense	$	2,093,604		$	(1,396,149	)	$	697,455
Total operating expense	$	2,120,908		$	(1,396,149	)	$	724,759
Operating income (expense)	$	58,052,541		$	(58,603,851	)	$	(551,310	)
Other income	$	129,896		$	(51,807	)	$	78,089
Interest expense	$	(868,121	)	$	665,311		$	(202,810	)
Loss on extinguishment of debt	$	(1,260,688	)	$	815,261		$	(445,427	)
Change in fair value of warrant and
derivative liabilities	$	-		$	(4,717,891	)	$	(4,717,891	)
Equity in earnings of affiliated company	$	-		$	29,327,829		$	29,327,829
Total other income (expense)	$	(1,998,977	)	$	26,038,703		$	24,039,726
Income before minority interest in income of
consolidated entity and income taxes	$	56,053,564		$	(32,565,148	)	$	23,488,416
Minority interest in loss of consolidated entity	$	(29,327,829	)	$	29,327,829		$	-
Income before income taxes	$	26,725,735		$	(3,237,319	)	$	23,488,416
Provision for income taxes	$	(1,840,000	)	$	1,840,000		$	-
Net income	$	24,885,735		$	(1,397,319	)	$	23,488,416
INCOME PER COMMON SHARE:
Basic	$	0.08		$	-		$	0.08
Diluted	$	0.06		$	-		$	0.06

	Condensed Consolidated Statement of Operations
Nine months ended February 28, 2006	As Previously Reported			Adjustments			As Restated
Revenue - licenses and royalties	$	70,000,000		$	(60,000,000	)	$	10,000,000
Total revenue	$	70,297,072		$	(60,000,000	)	$	10,297,072
Gross profit	$	70,193,721		$	(60,000,000	)	$	10,193,721
Selling , general and administrative expense	$	5,393,015		$	(2,875,826	)	$	2,517,189
Settlement and license expense	$	3,855,132		$	(1,937,078	)	$	1,918,054
Total operating expense	$	9,473,711		$	(4,812,904	)	$	4,660,807
Operating income	$	60,720,010		$	(55,187,096	)	$	5,532,914
Other income	$	264,271		$	(92,534	)	$	171,737
Interest expense	$	(1,181,635	)	$	665,311		$	(516,324	)
Loss on extinguishment of debt	$	(1,260,688	)	$	815,261		$	(445,427	)
Change in fair value of warrant and
derivative liabilities	$	-		$	(2,456,736	)	$	(2,456,736	)
Equity in earnings of affiliated company	$	-		$	28,607,664		$	28,607,664
Total other income (expense)	$	(2,179,253	)	$	27,538,966		$	25,359,713
Income before minority interest in income of
consolidated entity and income taxes	$	58,540,757		$	(27,648,130	)	$	30,892,627
Minority interest in loss of consolidated entity	$	(28,607,664	)	$	28,607,664		$	-
Income before income taxes	$	29,933,093		$	959,534		$	30,892,627

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Restatement of Previously Issued Financial Statements, continued

		Condensed Consolidated Statement of Operations
Nine months ended February 28, 2006		As Previously Reported		Adjustments		As Restated

Provision for income taxes	$	(1,880,000	)	$	1,880,000	$	-
Net income	$	28,053,093		$	2,839,534	$	30,892,627
INCOME PER COMMON SHARE:
Basic	$	0.09		$	0.01	$	0.10
Diluted	$	0.07		$	0.01	$	0.08

	Condensed Consolidated Statement of Cash Flows
Nine months ended February 28, 2006	As Previously Reported			Adjustments			As Restated
Net income	$	28,053,093		$	2,839,534		$	30,892,627
Equity in earnings of affiliated company	$	-		$	(28,607,664	)	$	(28,607,664	)
Change in fair value of warrant and
derivative liabilities	$	-		$	2,456,736		$	2,456,736
Net gain related to warrant re-pricing, reconveyance
and issuance	$	-		$	(538,208	)	$	(538,208	)
Loss on extinguishment of debt	$	1,260,688		$	(815,261	)	$	445,427
Non-cash compensation related to issuance of stock
options and vesting of warrants	$	150,013		$	(150,013	)	$	-
Common stock issued for services and other	$	-		$	207,869		$	207,869
Non-cash interest expense related to convertible
debentures, notes payable and warrants	$	1,136,047		$	(723,168	)	$	412,879
Expense related to warrant repricing and issuance	$	1,522,492		$	(1,522,492	)	$	-
Expense related to extension of expiration date of
stock options	$	-		$	125,000		$	125,000
Income of consolidated entity allocated to minority
interest	$	28,607,664		$	(28,607,664	)	$	-
Changes in licenses receivable	$	(32,100,000	)	$	33,600,000		$	1,500,000
Changes in accounts payable and accrued liabilities	$	2,060,510		$	(2,012,189	)	$	48,321

	Condensed Consolidated Statement of Cash Flows
Nine months ended February 28, 2006	As Previously Reported			Adjustments			As Restated
Net cash provided by operations	$	30,723,593		$	(23,747,520	)	$	6,976,073
Investment in affiliated company	$	-		$	(2,000,000	)	$	(2,000,000	)
Distributions from affiliated company	$	-		$	10,115,574		$	10,115,574
Net cash (used in) provided by investing activities	$	(3,376,683	)	$	8,115,574		$	4,738,891
Minority interest investment in consolidated entity	$	2,000,000		$	(2,000,000	)	$	-
Distributions of joint venture partner	$	(9,783,985	)	$	9,783,985		$	-
Net cash (used in) provided by financing activities	$	(7,459,717	)	$	7,783,985		$	324,268
Net increase in cash and cash equivalents	$	19,887,193		$	(7,847,961	)	$	12,039,232
Cash and cash equivalents, end of period	$	20,478,619		$	(7,847,961	)	$	12,630,658

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

3. License Agreements

In February 2005, the Company entered into two separate licensing agreements with one customer for the Company’s patent portfolio and Ignite microprocessor technology. The aggregate amount of the two licenses was $3,050,000, of which $2,950,000 was for licensing fees and $100,000 was for maintenance services. Maintenance under the agreement is expected to be provided over a period not to exceed four years. Maintenance revenue recognized during the three months ended August 31, 2006 was $6,250. The payment terms of the agreements required aggregate payments of $300,000 at the time of execution, three quarterly payments of $750,000 each on April 1, August 15, and November 15, 2005 and one final payment of $500,000 on February 15, 2006. The $500,000 payment due on February 15, 2006 was paid in March 2006. Total payments received in fiscal 2005 amounted to $1,050,000 and total payments received in fiscal 2006 amounted to $2,000,000. The agreements also provide for the future payment of royalties to the Company based on sales of product using the Ignite licensed technology. In connection with this license agreement, the Company became obligated to the former co-inventor of the patent portfolio technology for $207,600 pursuant to a July 2004 agreement under which the Company was obligated to pay a percentage of licensing proceeds to the co-inventor. The amount due was payable in four installments of $51,900. The co-inventor of the patent portfolio technology filed a lawsuit against the Company seeking damages and/or enforcement of a 2004 agreement (see Note 8). On February 14, 2007, a settlement of the litigation was finalized. Terms of the settlement require the Company to pay $3,400,000 in cash on February 14, 2007 and $3,000,000 on May 1, 2007, make a donation of $15,000 on February 14, 2007 on behalf of Russell H. Fish III to Maasai Power and Education Project, Inc., and pay Fish the equivalent of 4% of 50% of the next $100 million of gross license fees as they are collected by Phoenix Digital and as distributions are made to Patriot, after excluding the first $20 million collected by Phoenix Digital after December 1, 2006. Patriot's commitment to make payments to Fish related to such future license revenues will not exceed $2 million. At February 28, 2007, the Company has accrued the May 1, 2007 payment of $3,000,000 as a settlement fee payable. A liability for gross license fees due of approximately $244,000 is included in accrued expenses at February 28, 2007. During the three and nine month periods ended February 28, 2007, the Company recorded approximately $304,000 and $6,604,000 related to settlement and license expenses.

4. Note Receivable

On November 22, 2006, Patriot Scientific Corporation (the “Company”) entered into a Revolving Line of Credit Facility Agreement (the “Line of Credit Agreement”) with Holocom Networks (“Holocom”) which provided for borrowings of up to $700,000 under a revolving line of credit extended by the Company to Holocom. On November 22, 2006, the Company advanced Holocom $350,000 and further advanced an additional $230,000 during the three months ended February 28, 2007. Borrowings under the Line of Credit Agreement were used by Holocom for its operating cash flow needs. The borrowings bore interest at the prime rate, as announced by Bank of America, plus 2% per annum, and interest-only payments were due monthly. Pursuant to the terms of the Line of Credit Agreement, all unpaid principal and accrued and unpaid interest was due February 22, 2007. Borrowings under the Line of Credit Agreement were collateralized by substantially all of the assets of Holocom.

During the quarter ended February 28, 2007, the Company determined that the outstanding borrowings under the Line of Credit Agreement of $589,551, which included accrued interest and late fees of $9,551, were uncollectible as Holocom was unable to make the required interest payments. As a result, the Company foreclosed on the assets of Holocom. At the foreclosure sale, the Company acquired the patents, trademarks, equipment, inventory, and certain other collateral of Holocom pursuant to the terms of a Security Agreement entered into between the Company and Holocom in connection with the Line of Credit Agreement.

The Company originally accounted for its loan receivable, and related accrued interest, due from Holocom at cost. In accordance with SFAS No. 114, Accounting by Creditors for Impairments of a Loan, based on current information and events, the Company determined that it was unable to collect all amounts due from Holocom according to the contractual terms of the Line of Credit Agreement. As a result, the Company determined that the loan receivable was impaired. Accordingly, the Company recorded an impairment loss of $339,551 during the three months ended February 28, 2007. The impairment loss was determined based on an independent valuation of the assets of Holocom acquired in the foreclosure sale and management’s analysis of the fair value of such assets at time of acquisition.

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Note Receivable, continued

The fair value of the assets acquired in foreclosure of $250,000 was contributed to a newly formed entity, Scripps Secured Data, Inc. (“SSDI”), which will manufacture, market, and sell the former raceway product line previously sold by Holocom (see Note 5).

5. Investments in Affiliated Companies/License Agreement

On June 7, 2005, the Company entered into a Master Agreement (the “Master Agreement”) with Technology Properties Limited Inc., a California corporation (“TPL”), and Charles H. Moore (“Moore”), the co-inventor of certain of the Company’s technology, pursuant to which the Company and Moore resolved all legal disputes between them. Pursuant to the Master Agreement, the Company and TPL entered into the Limited Liability Company Operating Agreement of Phoenix Digital Solutions, LLC (the “LLC Agreement”) into which the Company and Moore contributed their rights to certain of the Company’s technologies. The Company believes, based upon consultation with its attorneys, it was not required by applicable law or other existing agreements to obtain approval for the contribution of the license rights to Phoenix Digital from stockholders or any parties other than its various warrant holders.

The Company and TPL each own 50% of the membership interests of Phoenix Digital, and each have the right to appoint one member of the three-member management committee. The two appointees are required to select a mutually acceptable third member of the management committee. Pursuant to the LLC Agreement, the Company and TPL agreed to establish a working capital fund for Phoenix Digital of $4,000,000, of which the Company’s contribution was $2,000,000. The working capital fund increases to a maximum of $8,000,000 as license revenues are achieved. The Company and TPL are obligated to fund future working capital requirements at the discretion of the management committee of Phoenix Digital in order to maintain working capital of not more than $8,000,000. Neither the Company nor TPL is required to contribute more than $2,000,000 in any fiscal year. Distributable cash and allocation of profits and losses will be allocated to the members in the priority defined in the LLC Agreement. Phoenix Digital has committed to pay a quarterly amount ranging between $500,000 and $1,000,000 (based upon a percentage of the working capital fund balance of Phoenix Digital) for supporting efforts to secure licensing agreements by the other member on behalf of Phoenix Digital. During the nine months ended February 28, 2006 and 2007, Phoenix Digital paid $500,000 and $2,934,075, respectively, to TPL pursuant to this commitment.

The Company is accounting for its investment in Phoenix Digital under the equity method of accounting, and accordingly has recorded its 50% share of Phoenix Digital’s net income of $30,401,594 during the nine months ended February 28, 2007 as an increase in its investment. Cash distributions of $29,419,880 received from Phoenix Digital during the nine months ended February 28, 2007 have been recorded as a reduction in the Company’s investment. The Company’s investment in Phoenix Digital is $4,934,628 at February 28, 2007 and has been recorded as “Investment in Affiliated Company”. The Company has recorded its 50% share of Phoenix Digital’s net income as “Equity in Earnings of Affiliated Company” in the accompanying condensed consolidated statements of operations for the three and nine months ended February 28, 2007 and 2006.

Concurrently with forming Phoenix Digital, the Company entered into a license agreement with a third party pursuant to which it received $10,000,000, which amount was recorded as license revenue during the quarter ended August 31, 2005. In connection with entering into the license agreement and forming Phoenix Digital, the Company incurred various cash and non-cash expenses. Direct, incremental cash costs incurred with the transactions included $170,000 paid to a committee of the Company’s board of directors for their efforts in consummating the transactions, approximately $1,328,000 paid to certain of the Company’s warrant holders to obtain their approval of the agreement and release of their lien and blocking rights. Additionally, $960,000 was paid to the former co-inventor of the technology.

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Investment in Affiliated Companies/License Agreement, continued

The Company also granted new warrants and agreed to re-price other outstanding warrants in order to obtain the necessary approvals from certain security interest holders as well as to obtain the release of their security interests in the Company’s intellectual property, and to finalize the LLC Agreement. The Company granted a warrant to TPL to acquire up to 3,500,000 shares of the Company’s common stock at a per share price of $0.125. The warrant has a term of seven years. At the date of grant, the right to acquire 1,400,000 common shares vested. The right to acquire the remaining 2,100,000 shares will vest in 700,000 increments only upon the Company’s common stock attaining a per share stock price of $0.50, $0.75 and $1.00. On February 21, 2006, February 22, 2006 and March 1, 2006 the rights to acquire the remaining 700,000 share increments vested as the Company’s stock price reached $0.50, $0.75 and $1.00, respectively. As additional consideration to the warrant holders for providing approval for the transaction, the Company agreed to reset the per share exercise price of approximately 35,000,000 warrants to $0.015 for which the warrant holders also conveyed other warrants to acquire 12,000,000 shares back to the Company. Further, the Company issued additional warrants to acquire approximately 290,000 shares of the Company’s common stock at a per share price of $0.03. The warrants issued and re-priced were valued using a Monte Carlo simulation model and the following assumptions: volatility of 101% to 229%, no dividends, risk-free interest rates of approximately 3.5% to 5.1%, and contractual terms ranging from two to seven years. The fair value of the warrants issued and re-priced in excess of previously recorded expense was approximately $83,000 and the fair value of the re-conveyed warrants was approximately $622,000. These amounts, together with the direct, incremental cash costs previously described, are recorded as an expense and included in settlement and license expense in the nine months ended February 28, 2006.

During the nine months ended February 28, 2007, Phoenix Digital entered into licensing agreements with third parties, pursuant to which it received aggregate proceeds of $64,869,000. License proceeds of $2,920,000 relating to an additional license agreement signed in February 2007 were received in March 2007. Phoenix Digital has recorded this amount as a license fee receivable.

The condensed balance sheet and statement of income of Phoenix Digital at February 28, 2007 and for the nine months then ended are as follows:

Condensed Balance Sheet
ASSETS:
Cash	$	7,500,220
License fees receivable		2,920,000
Prepaid expenses		15,000
Total assets	$	10,435,220

LIABILITIES AND MEMBERS’ EQUITY:
Accounts payable	$	629,934
Income tax payable		11,790
Members’ equity		9,793,496
Total liabilities and members’ equity	$	10,435,220

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Investment in Affiliated Companies/License Agreement, continued

Condensed Statement of Income
Revenues	$	67,788,985
Operating expenses		7,295,104
Operating income		60,493,881

Interest income		309,308
Net income	$	60,803,189

On February 2, 2007, the Company invested an aggregate of $370,000 in convertible preferred stock, representing all of the issued preferred stock and a 46% ownership interest, of and in SSDI, a California corporation that manufactures products that protect information transmitted over secure networks. The investment consisted of certain assets contributed by the Company to SSDI valued at $250,000 and cash of $120,000. The investment is represented by 2,100,00 shares of convertible preferred stock, and the shares are convertible at the Company’s option into shares of SSDI’s common stock on a one-to-one basis. The convertible preferred stock entitles the Company to receive non-cumulative dividends at the per annum rate of $0.04 per share, when and if declared by the Board of Directors of SSDI. The investment in SSDI’s convertible preferred stock also entitles the Company to a liquidation preference of $0.40 per share, plus an amount equal to all declared but unpaid dividends.

The Company reviewed the Preferred Stock Purchase Agreement and related agreements to determine whether the Company’s convertible preferred stock investment in SSDI was in substance an investment in common stock pursuant to EITF No. 02-14, Whether an Investor Should Apply the Equity Method of Accounting to Investments Other Than Common Stock. The Company determined that, because the liquidation preference is substantive, the subordination characteristics of the preferred stock are not substantially similar to the subordination characteristics of SSDI’s common stock. The Company also evaluated its voting rights pursuant to other agreements with SSDI and, when considered together with the guidance in EITF No. 02-14, believes that it does not have the ability to exercise significant influence over SSDI. As a result, the Company accounts for its investment in SSDI at cost.

The Company reviews its investments in affiliated companies to determine whether events or changes in circumstances indicate that its carrying amount may not be recoverable. The primary factors the Company considers in its determination are the financial condition, operating performance and near term prospects of the investee. If a decline in value is deemed to be other than temporary, the Company would recognize an impairment loss.

6. Convertible Debentures

From fiscal 2002 through fiscal 2005, the Company raised approximately $5,400,000 through the issuance of convertible debentures, having stated interest rates ranging from 8% to 12%, to a limited group of investors. The convertible debentures entitled the debenture holders to convert the principal, and any accrued interest thereon, into shares of the Company’s common stock for up to two years from the date of issuance.

The debentures were initially convertible into shares of common stock at conversion prices ranging from approximately $0.02 to $0.10 per share. The debentures contained provisions which allowed for the conversion rate to be reset on a periodic basis based on a comparison of the market price of the Company's common stock to the conversion price of the debentures. On those measurement dates where the market price was less than the conversion rate, a new conversion rate was set based on a weighted average of the market price for the ten days prior to the reset measurement date.

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Convertible Debentures , continued

Concurrent with the issuance of the convertible debentures, the Company issued to the debenture holders warrants to purchase shares of the Company's common stock. These warrants are exercisable for five years from the date of issuance at either initial negotiated exercise prices or prices equal to 115% of the volume weighted average price for our common stock for the ten days previous to the debenture date. The warrant exercise price is generally subject to being reset on each six-month anniversary of its issuance; however, if the warrant holder elects to have the warrant shares registered, then the exercise price is fixed at the price in effect on the date of the election.

The terms of the convertible debentures included certain features that were considered embedded derivative financial instruments, such as the conversion feature and a reset conversion feature which provided for a conversion of the debentures into shares of the Company’s common stock at a rate which was determined to be variable. Because the debentures were not conventional convertible debt, the Company was also required to record the related warrants at their fair values.

During the nine months ended February 28, 2006, the value of the warrant and derivative liabilities increased by $2,456,736, which is reflected as a component of other income (expense) in the accompanying condensed consolidated statements of operations.

During the three months ended February 28, 2006, the Company entered into two reset agreements with the debenture holders to fix the conversion price of the then outstanding debentures at their current price. The Company determined that one of the debt modifications did not result in a debt extinguishment under EITF Issue No. 96-19, Debtor’s Accounting for a Modification or Exchange of Debt Instruments, or EITF Issue No. 05-7, Accounting for Modifications to Conversion Options Embedded in Debt Instruments and Related Issues. In connection with the reset agreement of one of the outstanding debentures, the Company issued 7,000,000 warrants to the debenture holder as consideration for entering into the reset agreement. The Company determined that the issuance of the warrants, in connection with the reset agreement, resulted in a debt extinguishment under EITF Issue No. 96-19. Accordingly, the Company recorded the fair value of the warrants issued of $445,427 as a loss on extinguishment of debt in the accompanying consolidated statement of operations for the three and nine months ended February 28, 2006.

During the nine months ended February 28, 2006, holders of debentures with a principal balance of $880,667 converted their debentures, together with accrued interest thereon of approximately $119,000, into 30,819,187 shares of the Company's common stock.

As of May 31, 2006, all outstanding debentures were repaid or converted into shares of the Company’s common stock. As a result of the settlement of the remaining debentures during 2006, the Company reclassified $6,743,935 related to the fair values of all outstanding warrants at the date of settlement to additional paid-in capital.

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Convertible Debentures, continued

The following table presents the status and activity of the Company’s convertible debentures as of May 31, 2006:

							Conversion Prices
Series	Dates of Issuance		Original Principal		Principal Balance at May 31, 2006		Initial		Reset		Effective Registration Date		Shares Converted as of May 31, 2006		Warrant Shares Issued

A		4/23/02-	$	1,000,000	$	-	$	0.08616-	$	0.04190-		10/29/2002		24,099,548		12,859,175
		6/10/02						0.10289		0.04457

B		8/23/02-		605,000		-		0.05126-		0.04381-		3/7/2003		14,777,350		11,234,835
		1/24/03						0.0727		0.04722

C		3/24/02-		510,000		-		0.041-		0.041-		6/26/2003		10,470,554		9,377,943
		6/9/03						0.065		0.065

D		8/1/03-		547,500		-		0.0172-		0.0172-		11/18/2003		25,178,803		22,455,355
		10/21/03						0.048		0.0477

E		12/1/03-		1,527,500		-		0.0267-		0.0267-		6/7/2004		46,794,618		30,395,392
		5/11/04						0.10		0.10

F		3/23/04		723,168		-		0.09		0.09		Not Registered		20,877,430		8,035,192

G		9/28/04-		232,500		-		0.016710-		0.01670-		5/22/2006		8,267,358		8,259,678
		1/17/05						0.04		0.04

G		11/17/04-		257,500		-		0.016710-		0.01670-		Not Registered		14,107,672		13,431,137
		11/18/04						0.04		0.04
			$	5,403,168		-								164,573,333		116,048,707

No convertible debentures or warrants in connection with convertible debentures were issued during the year ended May 31, 2006.

The Company recorded the fair value of the derivative instruments and warrants as a debt discount which was amortized to interest expense over the term of the convertible debentures. During the nine months ended February 28, 2006, the Company recorded interest expense of $412,879 related to the amortization of the debt discount.

7. Stockholders’ Equity

During July 2006, the Company commenced its Board of Director approved stock buyback program in which the Company repurchases its outstanding common stock from time to time on the open market. As part of the program the Company purchased 10,779,027 shares of its common stock at an aggregate cost of $7,441,664 during the nine months ended February 28, 2007.

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Stockholders’ Equity, continued

The following table summarizes equity transactions during the nine months ended February 28, 2007:

	Common Stock
	Shares		Amounts		Additional Paid-in Capital			Accumulated Deficit			Treasury Stock

Balance June 1, 2006		366,199,765	$	3,661	$	69,551,981		$	(58,728,091	)	$	-

Exercise of warrants and options at $0.02 to $0.40 per share		787,500		8		113,992			-			-
Cashless exercise of warrants		22,459,880		225		(225	)		-			-
Extension of stock options previously issued to a consultant		-		-		324			-			-
Non-cash compensation		-		-		2,359,035			-			-
Repurchase of common stock for treasury		-		-		-			-			(7,441,664	)
Net income		-		-		-			13,725,834			-
Balance February 28, 2007		389,447,145	$	3,894	$	72,025,107		$	(45,002,257	)	$	(7,441,664	)

Stock Options and Warrant Activity

As of February 28, 2007, 100,000 options were outstanding pursuant to our 1996 Stock Option Plan exercisable at $0.07 per share expiring in 2009; 475,000 options were outstanding pursuant to our 2001 Stock Option Plan exercisable at a range of $0.07 to $0.86 per share expiring through 2011; 2,050,000 options were outstanding pursuant to our 2003 Stock Option Plan exercisable at a range of $0.05 to $0.17 per share expiring through 2011; and 3,120,000 options were outstanding pursuant to our 2006 Stock Option Plan exercisable at a range of $0.60 to $0.70 per share expiring through 2012.

During the quarter ended August 31, 2006, we issued options to acquire 1,500,000 shares of our common stock at a per share price of $0.17 to an officer outside of the above referenced plans.

During the quarter ended November 30, 2006, we issued options to acquire 230,000 shares of our common stock at a per share price of $0.86 to employees pursuant to the 2001 Stock Option Plan.

During the quarter ended February 28, 2007, we issued options to acquire 1,070,000 shares of our common stock at a per share price of $0.60 to directors and employees pursuant to the 2006 Stock Option Plan.

During the nine months ended February 28, 2007, directors exercised stock options to purchase 515,000 shares of common stock for aggregate proceeds of $41,750.

During the nine months ended February 28, 2007, we recorded $2,359,035 of non cash compensation expense related to stock options issued and vesting of stock options and warrants previously granted.

As of February 28, 2007, we had warrants outstanding to purchase 29,906,015 common shares at exercise prices ranging from $0.02 to $1.00 per share, expiring at various dates through 2012. Some of these outstanding warrants were not exercisable as of February 28, 2007 as they are subject to meeting vesting criteria. During the nine months ended February 28, 2007, we issued no warrants to purchase shares of common stock, investors exercised warrants to purchase 272,500 shares of common stock for proceeds of $72,250 and investors exercised warrants of 22,732,380 to purchase 22,459,880 shares of common stock on a cashless basis.

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Stockholders’ Equity, continued

In connection with a previous debt agreement, the Company entered into an Antidilution Agreement (the “Antidilution Agreement”) with Swartz Private Equity, LLC (“Swartz”) wherein the Company was obligated to issue to Swartz warrants equal to 11% of the common stock issued between January 28, 2002 and March 11, 2002, 20% of the common stock issued between March 12, 2002 and April 1, 2003, and after April 1, 2003, 30% of the common stock issued to any parties other than Swartz. There were no warrants issued during the three month periods ended August 31, 2006 and 2005, nor were warrants issued during September 2006, in connection with the Antidilution agreement. On October 10, 2006, the Company entered into an Approval Rights Agreement and Termination of Antidilution Agreement and Addendum to Warrants (the “Termination Agreement”) with Swartz to terminate the Antidilution Agreement. In consideration for entering into the Termination Agreement, the Company agrees to obtain Swartz’s written approval at least 30 days prior to entering into (i) any acquisition of any business entity or asset of any kind where the aggregate number of shares of common stock and derivative securities (on a fully diluted basis) issued as consideration for the acquisition equals or exceeds 10% of the number of shares of common stock of the Company outstanding at the time of the acquisition (on a fully diluted basis) or (ii) any acquisition (regardless of size) by the Company of any business entity or asset of any kind that is not unanimously approved by the Company’s board of directors.

8. Commitments and Contingencies

Litigation

Patriot Scientific Corporation v. Russell Fish

On April 6, 2006, we filed a declaratory relief lawsuit against Russell Fish and The Fish Family Trust in the United States District Court for the Southern District of California. As a consequence of licensing agreements entered into by or on behalf of Patriot, by Patriot's previous management, Mr. Fish presented demands for payment by us under his July 2004 agreement related to the Inventorship Litigation. We contended that Mr. Fish had been paid all sums that may have been owed to him. Our action sought declaratory relief that no further sums were owed to Mr. Fish. Also, on April 6, 2006, Fish and, later, Robert Anderson, allegedly as trustee of The Fish Family Trust, filed a lawsuit against the Company in the District Court of Dallas County, Texas. The case was subsequently removed to the United States District Court for the Northern District of Texas. The lawsuit was based on an alleged breach of the contract entered into on July 27, 2004 and sought enforcement of the contract or damages. The California action was transferred to the Northern District of Texas. Mediation commenced on September 11, 2006. On February 14, 2007, a settlement of this litigation was finalized. Terms of the settlement require the Company to pay $3,400,000 in cash on February 14, 2007 and $3,000,000 on May 1, 2007, make a donation of $15,000 on February 14, 2007 on behalf of Russell H. Fish III to Maasai Power and Education Project, Inc., and pay Fish the equivalent of 4% of 50% of the next $100 million of gross license fees as they are collected by Phoenix Digital and as distributions are made to Patriot, after excluding the first $20 million collected by Phoenix Digital after December 1, 2006. Patriot's commitment to make payments to Fish related to such future license revenues will not exceed $2 million.

Lowell Giffhorn Arbitration

On September 23, 2005, Lowell Giffhorn, a former executive officer and a former director of Patriot, submitted a demand for arbitration with the American Arbitration Association related to the termination of Mr. Giffhorn's employment with the Company. Mr. Giffhorn asserts that the termination of his employment with the Company was unlawful, retaliatory, wrongful, violated public policy, violated the covenant of good faith and fair dealing and violated securities laws. Mr. Giffhorn has demanded damages of approximately $4,500,000 (excluding claims for punitive damages and attorneys fees). The Company denies the allegations and believes the claims to be frivolous and totally devoid of merit. The Company has retained litigation counsel and intends to vigorously defend the claims. The amount, if any, of ultimate liability with respect to the foregoing cannot be determined. Despite the inherent uncertainties of litigation, the Company at this time does not believe that Mr. Giffhorn's claim will have a material adverse impact on its financial condition, results of operations, or cash flows.

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Commitments and Contingencies, continued

Patent Litigation

Pursuant to the joint venture that the Company entered into in June 2005 TPL (in settlement of inventorship/ownership litigation between the parties, and in return for a 50-50 sharing of net licensing and enforcement revenues), the Company granted TPL the complete and exclusive right to enforce and license its microprocessor patent portfolio. The Company then dismissed its patent infringement claims against Fujitsu Computer Systems, Inc.; Matsushita Electric Corporation of America; NEC Solutions (America) Inc.; Sony Electronics Inc.; and Toshiba America Inc., and certain related entities of these defendants which had been pending in the Federal District Court for the Northern District of California. Thereafter, TPL, on behalf of the TPL/Patriot joint venture and Patriot, filed patent infringement actions against certain of the foregoing defendants (except Sony) and their related entities in the Federal District Court for the Eastern District of Texas, which litigation is currently pending. Litigation is not currently pending with regard to Fujitsu or NEC and certain of NEC’s subsidiaries as listed below.

In February 2006, a license agreement was entered into with Fujitsu Corporation regarding the Company's patent portfolio, and in connection with that transaction, litigation involving Fujitsu and TPL and the Company in both California and Texas was dismissed. A Claims Construction Hearing is scheduled for May 3, 2007 in The United States District Court for the Eastern District of Texas.

In February 2007, a license agreement was entered into with: NEC Corporation, NEC Corporation of America, Inc., NEC Display Solutions of America, Inc. and NEC Unified Solutions, Inc. In connection with that transaction, the above named defendants, excluding NEC Electronics America, Inc., were dismissed from the lawsuit.

Profit Sharing Plan

The Company has a savings and profit-sharing plan that allows participants to make contributions by salary reduction pursuant to Section 401(k) of the Internal Revenue Code. At the Company’s discretion, the Company may match contributions at 20% of the employee’s contribution up to 6% of the employee’s salary. The Company contributions are vested 20% per year beginning with the first year of service. The Company made no matching contributions to the plan in fiscal 2006. On December 31, 2005, the Company terminated the plan.

401(k) Plan

In January 2006, the Company adopted a retirement plan that complies with Section 401(k) of the Internal Revenue Code. All employees are eligible to participate in the plan. The Company matches 50% of each participant’s voluntary contributions, subject to a maximum contribution of 6% of the participant’s compensation. Participants fully vest in the Company’s contributions after three years of vesting service. On April 1, 2007 an amendment was made to the Company’s 401(k) plan allowing vesting to take place evenly over the three year vesting service period. The Company’s matching contributions for the nine months ended February 28, 2007 were $8,237.

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Commitments and Contingencies, continued

Employment Contract

During the quarter ended August 31, 2005, the Company terminated two of its officers, each of whom had an employment contract with the Company. One of the officers agreed to accept as severance approximately $150,000 and to have the maturity date of options held by him extended for one year. Further, the Company agreed to accelerate the vesting of all outstanding options held by the officer and to extend their term to June 2006. The Company recorded an expense of approximately $125,000 related to this option modification in the quarter ended August 31, 2005.

The Company has not reached an agreement with the other officer; however, it accrued approximately $50,000 during the three month period ended August 31, 2005 for amounts which it believes may be due to

this individual. The former officer has filed a complaint against the Company seeking arbitration and claiming he is owed approximately $4,500,000 (see above). The Company believes the claim is without merit and intends to vigorously defend itself.

Guarantees and Indemnities

The Company has made certain guarantees and indemnities, under which it may be required to make payments to a guaranteed or indemnified party. The Company indemnifies its directors, officers, employees and agents to the maximum extent permitted under the laws of the State of Delaware. In connection with its facility leases, the Company has indemnified its lessors for certain claims arising from the use of the facilities.

The duration of the guarantees and indemnities varies, and in many cases is indefinite. These guarantees and indemnities do not provide for any limitation of the maximum potential future payments the Company could be obligated to make. Historically, the Company has not been obligated to make any payments for these obligations and no liabilities have been recorded for these guarantees and indemnities in the accompanying condensed consolidated balance sheets.

9. Subsequent Events

During the period March 1, 2007 through April 20, 2007, Phoenix Digital entered into license agreements with third parties, with proceeds totaling $22,140,000.

On March 5, 2007, the Company received proceeds of $100,000 from an investor who exercised warrants to purchase 1,000,000 shares of common stock.

On March 20, 2007, an investor exercised warrants of 10,702,243 to purchase 10,424,578 shares of common stock on a cashless basis.

In a press release dated February 22, 2007, the Company announced dividends of $0.02 per share to shareholders and qualified warrant holders of record as of March 6, 2007. The dividend of $8,114,774 was paid on April 9, 2007. In the same press release, the Company announced the Board of Directors semi-annual dividend policy contingent upon the financial condition of the Company, other possible applications of available resources, and relevant business considerations.

On March 27, 2007, the Company entered into an 18 month revolving line of credit with SSDI for a maximum amount of $500,000. If the Company does not provide notice to SSDI at least 90 days prior to the maturity date, the maturity date automatically extends 12 months. The line of credit is collateralized by all assets presently owned or hereafter acquired by SSDI. On March 28, 2007, the Company advanced $150,000 under terms of the agreement, and on April 16, 2007 the Company advanced $100,000 under terms of the agreement.

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements

Subsequent Events, continued

The line carries a floating interest rate which is defined as the prime rate as announced by Bank of America. At March 31, 2007, the interest rate on the note was 8.25%. The borrower is required to make minimum monthly payments on the line consisting of unpaid and accrued interest on the first day of the month following the initial advance.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

THE FOLLOWING DISCUSSION INCLUDES FORWARD-LOOKING STATEMENTS WITH RESPECT TO OUR FUTURE FINANCIAL PERFORMANCE. ACTUAL RESULTS MAY DIFFER MATERIALLY FROM THOSE CURRENTLY ANTICIPATED AND FROM HISTORICAL RESULTS DEPENDING UPON A VARIETY OF FACTORS, INCLUDING THOSE DESCRIBED BELOW UNDER THE SUB-HEADING, "RISK FACTORS" SEE ALSO OUR ANNUAL REPORT ON FORM 10-KSB FOR THE YEAR ENDED MAY 31, 2006.

Overview

During the fiscal years ended May 31, 2005 and May 31, 2006, the Company entered into agreements for the licensing of its technology with Advanced Micro Devices Inc. ("AMD") and Intel Corporation, among the largest of the microprocessor manufacturers. During the 2006 fiscal year, the Company entered into licensing agreements with Hewlett-Packard, Fujitsu and Casio through its joint venture entity, Phoenix Digital. Additional licensing agreements for the use of the Company’s technology were signed through its joint venture entity during the nine months ended February 28, 2007. We believe that these agreements represent validation of the Company's position that its intellectual property was and is being infringed by major manufacturers of microprocessor technology. Also, we believe the agreements demonstrate the value of the Company's intellectual property in that they are "arms length" transactions with major electronics manufacturers.

In June 2005, the Company entered into a series of agreements with Technology Properties Limited, Inc. (“TPL”) and others to facilitate the pursuit of infringers of its intellectual property. The Company intends to continue its joint venture with TPL to pursue license agreements with infringers of its technology. Management believes that utilizing the option of working through TPL, as compared to creating and using a Company licensing team for those activities, avoids a competitive devaluation of the Company’s principal assets and is a prudent way to achieve the desired results as the Company seeks to obtain fair value from users of its intellectual property.

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

On September 8, 2006, the Company determined that the manner in which it had accounted for the reset conversion feature and embedded put option of certain of its convertible debentures was not in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 133, Accounting For Derivative Instruments and Hedging Activities, as amended, and Emerging Issues Task Force (“EITF”) Issue No. 00-19, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company's Own Stock. The Company determined that the reset conversion feature was an embedded derivative instrument and that the conversion option was an embedded put option pursuant to SFAS No. 133. The accounting treatment of derivative financial instruments required that the Company record the derivatives and related warrants at their fair values as of the inception date of the convertible debenture agreements and at fair value as of each subsequent balance sheet date. In addition, under the provisions of EITF No. 00-19, as a result of entering into the convertible debenture agreements, the Company was required to classify all other non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was required to be recorded as non-operating, non-cash income or expense at each balance sheet date. If the fair value of the derivatives was higher at the subsequent balance sheet date, the Company was required to record a non-operating, non-cash charge. If the fair value of the derivatives was lower at the subsequent balance sheet date, the Company was required to record non-operating, non-cash income. Accordingly, in connection with its restatement adjustments, the Company has appropriately reflected the non-operating, non-cash income or expense resulting from changes in fair value. The Company had previously not recorded the embedded derivative instruments as a liability and did not record the related changes in fair value. The Company did not have any derivative instruments at May 31, 2006 as all derivative instruments were settled prior to May 31, 2006.

In addition, the Company determined the manner in which it accounted for its interest in Phoenix Digital was not in accordance with appropriate accounting literature. Beginning in June 2005, the Company accounted for its interest in Phoenix Digital as a variable interest entity, as defined in FASB Interpretation 46(R). Accordingly, the accounts and transactions of Phoenix Digital were consolidated with those of the Company and the ownership interest of the other member of Phoenix Digital was presented as a minority interest in the condensed consolidated financial statements of the Company for the periods August 31, 2005, November 30, 2005 and February 28, 2006. The Company has reassessed its accounting for its interest in Phoenix Digital and after further consideration of FIN 46(R) and other authoritative literature, has corrected its accounting policy to account for its interest in Phoenix Digital in accordance with the equity method of accounting for investments, as the Company did not have a controlling financial interest in Phoenix Digital and determined that it was not the primary beneficiary of the relationship.

Based on the foregoing, the Company’s Board of Directors determined that the Company was required to restate its financial results for the year ended May 31, 2005 and for the three month periods ended August 31, 2005, November 30, 2005 and February 28, 2006.

See Note 2 to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for a summary of the effects of the restatement adjustments on the Company's condensed consolidated financial statements. The information provided in this Management's Discussion and Analysis of Financial Condition and Results of Operations reflects the effect of the restatement adjustments.

Critical Accounting Policies and Estimates

Our condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, which require us to make estimates and judgments that significantly affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. Actual results could differ from those estimates, and such differences could affect the results of operations reported in future periods. We believe the following critical accounting policies affect our most significant estimates and judgments used in the preparation of our condensed consolidated financial statements.

1. Revenue Recognition

Accounting for revenue recognition is complex and affected by interpretations of guidance provided by several sources, including the Financial Accounting Standards Board (“FASB”) and the Securities and Exchange Commission (“SEC”). This guidance is subject to change. We follow the guidance established by the SEC in Staff Accounting Bulletin No. 104, as well as generally accepted criteria for revenue recognition, which require that, before revenue is recorded, there is persuasive evidence of an arrangement, the fee is fixed or determinable, collection is reasonably assured, and delivery to our customer has occurred. Applying these criteria to certain of our revenue arrangements requires us to carefully analyze the terms and conditions of our license agreements. Revenue from our technology license agreements is generally recognized at the time we enter into a contract and provide our customer with the licensed technology. We believe that this is the point at which we have performed all of our obligations under the agreement; however, this remains a highly interpretive area of accounting and future license agreements may result in a different method of revenue recognition. Fees for maintenance or support of our licenses are recorded on a straight-line basis over the underlying period of performance.

2. Assessment of Contingent Liabilities

We are involved in various legal matters, disputes, and patent infringement claims which arise in the ordinary conduct of our business. We accrue for estimated losses at the time when we can make a reliable estimate of such loss and it is probable that it has been incurred. By their very nature, contingencies are difficult to estimate. We continually evaluate information related to all contingencies to determine that the basis on which we have recorded our estimated exposure is appropriate.

3. Stock Options and Warrants

We account for equity issuances to non-employees in accordance with Statement of Financial Accounting Standards ("SFAS") No. 123, Accounting for Stock Based Compensation , and Emerging Issues Task Force ("EITF") Issue No. 96-18, Accounting for Equity Instruments that are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods and Services . All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the third-party performance is complete or the date on which it is probable that performance will occur.

Prior to June 1, 2006, we accounted for stock-based compensation issued to employees using the intrinsic value method of accounting prescribed by Accounting Principles Board ("APB") Opinion No. 25, Accounting for Stock Issued to Employees and related pronouncements. Under this method, compensation expense was recognized over the respective vesting period based on the excess, on the date of grant, of the fair value of our common stock over the grant price, net of forfeitures. Deferred stock-based compensation was amortized on a straight-line basis over the vesting period of each grant.

On June 1, 2006, we adopted SFAS No. 123(R), Share-Based Payment, which requires the measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors related to our stock option plans based on estimated fair values. We adopted SFAS No. 123(R) using the modified prospective transition method, which requires the application of the accounting standard as of June 1, 2006, the first day of our fiscal year 2007. Our condensed consolidated financial statements as of and for the nine months ended February 28, 2007 reflect the impact of adopting SFAS No. 123(R). In accordance with the modified prospective transition method, our consolidated financial statements for prior periods have not been restated to reflect, and do not include, the impact of SFAS No. 123(R). The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our consolidated statement of operations. As stock-based compensation expense recognized in the condensed consolidated statement of operations for the nine months ended February 28, 2007 is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures. SFAS No. 123(R) requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The estimated average forfeiture rate for the nine months ended February 28, 2007 of 5% was based on historical forfeiture experience and estimated future employee forfeitures. In our pro forma information required under SFAS No. 123 for the periods prior to fiscal 2007, we accounted for forfeitures as they occurred.

Employee stock-based compensation expense recognized under SFAS No. 123(R) for the nine months ended February 28, 2007 was approximately $2,356,000, determined by the Black-Scholes valuation model.

4. Debt Discount

We have issued warrants as part of our convertible debentures and other financings. We value the warrants using the Black-Scholes pricing model based on expected fair value at issuance and the estimated fair value is recorded as debt discount. The debt discount is amortized to non-cash interest over the life of the debenture assuming the debenture will be held to maturity, which is normally two years. If the debenture is converted to common stock previous to its maturity date, any debt discount not previously amortized is expensed to non-cash interest. As of May 31, 2006, the debt discount has been fully amortized as the debt instruments were settled prior to May 31, 2006.

5. Derivative Financial Instruments

In connection with the issuance of certain convertible debentures, the terms of the debentures included a reset conversion feature which provided for a conversion of the debentures into shares of the Company's common stock at a rate which was determined to be variable. The conversion option was therefore deemed to be an embedded put option pursuant to SFAS No. 133, Accounting For Derivative Instruments and Hedging Activities , as amended, and EITF Issue No. 00-19, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company's Own Stock . The Company determined that the reset conversion feature was an embedded derivative instrument and that the conversion option was an embedded put option pursuant to SFAS No. 133. The accounting treatment of derivative financial instruments required that the Company record the derivatives and related warrants at their fair values as of the inception date of the convertible debenture agreements and at fair value as of each subsequent balance sheet date. In addition, under the provisions of EITF No. 00-19, as a result of entering into the convertible debenture agreements, the Company was required to classify all other non-employee warrants as derivative liabilities and record them at their fair values at each balance sheet date. Any change in fair value was recorded as non-operating, non-cash income or expense at each balance sheet date. If the fair value of the derivatives was higher at the subsequent balance sheet date, the Company recorded a non-operating, non-cash charge. If the fair value of the derivatives was lower at the subsequent balance sheet date, the Company recorded non-operating, non-cash income. As of May 31, 2006, the Company does not have any outstanding derivative instruments as the related debt instruments were settled prior to May 31, 2006.

6. Patents and Trademarks

Patents and trademarks are carried at cost less accumulated amortization and are amortized over their estimated useful lives of four years. The carrying value of patents and trademarks is periodically reviewed and impairments, if any, are recognized when the expected future benefit to be derived from an individual intangible asset is less than its carrying value.

7. Income Taxes

The Company must assess the likelihood that it will be able to recover its deferred tax assets. If recovery is not likely, the Company must increase its provision for taxes by recording a valuation allowance against the deferred tax assets that the Company estimates will not ultimately be recoverable. The Company believes that a substantial majority of the deferred tax assets recorded on its balance sheet will ultimately be recovered. However, should there be a change in the Company’s ability to recover the deferred tax assets, the tax provision would increase in the period in which the Company determined that the recovery was not probable.

8. Investment in Affiliated Companies

The Company has a 50% interest in Phoenix Digital. This investment is accounted for using the equity method of accounting since the investment provides the Company the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if the Company has an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee’s Board of Directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize the Company’s share of net earnings or losses of the investee and is recognized in the condensed consolidated statement of operations in the caption “Equity in earnings of affiliated company”.

The Company owns 100% of the preferred stock of Scripps Secured Data, Inc. (“SSDI”) This investment is accounted for at cost as the investment is in preferred shares which do not share in the earnings of SSDI and the Company does not have the ability to the ability to exercise significant influence over SSDI.

Results of Operations

Comparison of the Nine Months Ended February 28, 2007 and Nine Months Ended February 28, 2006.

In June 2005, we entered into an agreement with Intel Corporation licensing our intellectual property for a one-time payment of $10,000,000. The license revenue was recognized in the quarter ended August 31, 2005. During the nine month period ended February 28, 2007 no such agreement was signed by the Company. In connection with entering into the agreement with Intel Corporation, we entered into an agreement with the co-owner of our patented technologies, through which we settled all legal disputes between us and agreed to jointly pursue others who have infringed upon our joint rights. Future licensing agreements for the use of the Company’s technology are being made through a joint venture entity that is accounted for in accordance with the equity method of accounting for investments and, accordingly, the financial results of the joint venture are being recorded in the other income section of the Company’s condensed consolidated statement of operations. Product sales amounting to approximately $297,000 and $67,000 were also recorded in the nine month periods ended February 28, 2006 and 2007, respectively, in connection with communications products that are no longer marketed by the Company. Inventory associated with the sales of these communications products is carried at zero value. Cost of sales of approximately $103,000 for the nine months ended February 28, 2006 consists of payments made to subcontractors for materials and labor in connection with the product sales. For the nine months ended February 28, 2007, no such costs were incurred on the product sales. Total revenues amounted to approximately $10,297,000 and $67,000 for the nine months ended February 28, 2006 and 2007, respectively.

Research and development expenses decreased from approximately $226,000 for the nine months ended February 28, 2006 to zero for the nine months ended February 28, 2007. Presently, we do not expect to replace recently discontinued “in house” research and development operations. However, the Company may utilize consultants and other outsourced contractors for research and development activities in future periods.

Selling, general and administrative expenses increased from approximately $2,517,000 for the nine months ended February 28, 2006 to approximately $5,915,000 for the nine months ended February 28, 2007. Legal and accounting related expenses increased by approximately $1,003,000 for the nine months ended February 28, 2007 compared with the nine months ended February 28, 2006 related to legal and accounting matters in connection with the restatement of the Company’s financial statements for the fiscal years 2005, 2004, 2003 and 2002, as well as the quarterly reports for the periods ended August 31, 2005, November 30, 2005 and February 28, 2006 and the Company’s required compliance with Sarbanes-Oxley procedures. Legal expenses related to a dispute with a former executive officer as well as other legal proceedings involving the interests of a co-inventor of a portion of the Company’s technology and other legal matters contributed to the increase in legal expenses for the nine months ended February 28, 2007. Salary costs and related expenses included non-cash expenses associated with the fair value of options granted during the period in accordance with SFAS No. 123(R). On June 5, 2006, 1,500,000 options were granted to the chief executive officer of the Company resulting in non-cash compensation expense amounting to approximately $1,527,000. On October 23, 2006, 230,000 options were granted to employees resulting in non-cash compensation expense of approximately $184,000. On February 9, 2007, 1,070,000 options were granted to employees and directors resulting in non-cash compensation expense of approximately $584,000. Additional non-cash compensation for the nine months ended February 28, 2007 amounted to $61,000 for vesting of employee stock options in accordance with SFAS No 123(R). No such compensation expense was incurred for the nine months ended February 28, 2006. Public and investor relations expenses increased by approximately $197,000 for the nine months ended February 28, 2007 as compared with the nine months ended February 28, 2006 as a result of a change in the Company’s public relations firm and one time contracts with investor relations consultants. Other salary expenses increased by approximately $167,000 for the nine months ended February 28, 2007 as compared with the nine months ended February 28, 2006 due to bonuses and 401(k) employer matching of which no such expense was incurred for the nine months ended February 28, 2006. Insurance expense increased by approximately $110,000 for the nine months ended February 28, 2007 as compared with the nine months ended February 28, 2006 primarily as a result of increased costs of directors and officers insurance coverage. Travel and related expenses increased approximately $19,000 for the nine months ended February 28, 2007 as compared with the nine months ended February 28, 2006 due to increased travel to attend various lawsuit mediations. Decreases in expenses were recorded for the nine months ended February 28, 2007 as compared with the nine months ended February 28, 2006 for rent, office supplies, patent enforcement expenses, website, marketing, utilities and for other expenses in the approximate amounts of $38,000, $12,000, $74,000, $22,000, $20,000, $8,000 and $280,000, respectively.

Settlement and license expenses amounting to approximately $1,918,000 were recorded during the three months ended August 31, 2005 in connection with the agreements involving the formation of a joint venture and, separately, a license agreement with Intel Corporation. The expenses consisted of both cash and non-cash elements related to incremental, direct costs of completing the transactions. In connection with the transactions, it was necessary for the Company to obtain the consent of certain debenture and warrant holders. The necessary consents, together with certain warrants held by the debenture holders and the release of their security interests in our intellectual property, were obtained in exchange for cash, new warrants and repriced warrants. The expenses resulted primarily from cash payments to debt holders of approximately $1,300,000, to co-owners of various intellectual property assets of approximately $960,000 and to a committee of the Company’s board of directors of approximately $170,000. Non-cash expenses totaled approximately $82,000 and resulted primarily from the incremental value of the effect of repricing various warrants and granting other warrants in excess of the expense previously recognized for warrants granted to these security holders. Offsetting the non-cash expenses were non-cash benefits to the Company from the reconveyance of warrants, amounting to approximately $622,000. During the nine months ended February 28, 2007, the Company recorded $6,604,000 of settlement and license expense relating to the mediation agreement with Fish (see Note 8 for more information).

Other income and expenses for the Company for the nine months ended February 28, 2007 included equity in the earnings of Phoenix Digital. The investment is accounted for in accordance with the equity method of accounting for investments. The Company’s investment in the joint venture for the nine months ended February 28, 2007 provided income after expenses in the amount of approximately $30,402,000 resulting from licensing agreements for our intellectual property with Sony, Nikon, Seiko Epson, Pentax, Olympus, Kenwood, Agilent, Lexmark, Schneider Electric, NEC Corporation and its selected subsidiaries and Funai Electric for one time payments. The Company’s investment in the joint venture provided net income after expenses in the amount of approximately $28,608,000 for the nine months ended February 28, 2006. Total other income and expense for the nine months ended February 28, 2007 amounted to net other income of approximately $30,561,000 compared with total other income and expense for the nine months ended February 28, 2006 of net other income amounting to approximately $25,360,000. Changes in the fair value of warrant and derivative liabilities amounted to net other expense for the nine months ended February 28, 2006 of approximately $2,457,000 with no corresponding amount for the nine months ended February 28, 2007 as all convertible debt had been retired in prior fiscal periods. Non-cash adjustments to interest expense for the nine months ended February 28, 2006 amounted to expenses of approximately $413,000 resulting from amortization of debt discount and conversion of the remaining debentures. During the nine months ended February 28, 2006 the Company recorded a loss on debt extinguishment of $445,000 related to the 7,000,000 warrants issued to a debenture holder as consideration for entering into the reset agreements. Interest income and other income increased from approximately $172,000 for the nine months ended February 28, 2006 to approximately $499,000 for the nine months ended February 28, 2007 as interest bearing account balances increased from license revenues. During the nine months ended February 28, 2007 the Company recorded an impairment charge on the value of its note receivable from Holocom Networks, Inc. of approximately $340,000. (see Note 4 for more information).

During the nine months ended February 28, 2007, the Company recorded a provision for income taxes of $4,382,911 related to federal and state taxes. Also, during the nine months ended February 28, 2006 and 2007, the Company utilized approximately $3,000,000 and $32,000,000, respectively, of its available federal net operating loss carry-forwards and approximately $3,000,000 and $16,700,000, respectively, of its available state net operating loss carry-forwards to offset its taxable income arising in the respective quarters.

The Company recorded net income (as restated) for the nine months ended February 28, 2006 of $30,892,627 compared with net income of $13,725,834 for the nine months ended February 28, 2007.

Comparison of the Three Months Ended February 28, 2007 and Three Months Ended February 28, 2006.

In June 2005, we entered into an agreement with Intel Corporation licensing our intellectual property for a one-time payment of $10,000,000. During the three month periods ended February 28, 2007 and 2006, no such agreement was signed by the Company. In connection with entering into the agreement with Intel Corporation, we entered into an agreement with the co-owner of our patented technologies, through which we settled all legal disputes between us and agreed to jointly pursue others who have infringed upon our joint rights. Future licensing agreements for the use of the Company’s technology are being made through a joint venture entity that is accounted for in accordance with the equity method of accounting for investments and, accordingly, the financial results of the joint venture are being recorded in the Other Income section of the Company’s Condensed consolidated Statement of Operations. Product sales amounting to approximately $277,000 and $22,000 were also recorded in the three month periods ended February 28, 2006 and 2007, respectively, in connection with communications products that are no longer marketed by the Company. Inventory associated with the sales of these communications products is carried at zero value. Cost of sales of approximately $103,000 for the three months ended February 28, 2006 consists of payments made to subcontractors for materials and labor in connection with the product sales. For the three months ended February 28, 2007, no such costs were incurred on the product sales. Total revenues amounted to approximately $277,000 and $22,000 for the three months ended February 28, 2006 and 2007, respectively.

Research and development expenses decreased from approximately $27,000 for the three months ended February 28, 2006 to zero for the three months ended February 28, 2007. Presently, we do not expect to replace recently discontinued “in house” research and development operations. However, the Company may utilize consultants and other outsourced contractors for research and development activities in future periods.

Selling, general and administrative expenses increased from approximately $697,000 for the three months ended February 28, 2006 to approximately $1,446,000 for the three months ended February 28, 2007. Legal and accounting related expenses increased by approximately $211,000 for the three months ended February 28, 2007 compared with the three months ended February 28, 2006 related to legal and accounting matters in connection with the restatement of the Company’s financial statements for the fiscal years 2005, 2004, 2003 and 2002, as well as the quarterly reports for the periods ended August 31, 2005, November 30, 2005 and February 28, 2006 and the Company’s required compliance with Sarbanes-Oxley procedures. Legal expenses related to a dispute with a former executive officer as well as other legal proceedings involving the interests of a co-inventor of a portion of the Company’s technology and other legal matters contributed to the increase in legal expenses for the three months ended February 28, 2007. Salary costs and related expenses included non-cash expenses associated with the fair value of options granted during the period in accordance with SFAS No. 123(R). On February 9, 2007, 1,070,000 options were granted to employees and directors resulting in non-cash compensation expense of approximately $584,000. Additional non-cash compensation for the three months ended February 28, 2007 amounted to approximately $2,000 for vesting of employee stock options in accordance with SFAS 123(R). No such compensation expense was incurred for the three months ended February 28, 2006. Payments of Board of Director fees increased by approximately $67,000 for the three months ended February 28, 2007 as compared to the three months ended February 28, 2006 due to the initiation of monthly director payments in the third quarter of fiscal 2006. Insurance expenses increased by approximately $38,000 for the three months ended February 28, 2007 as compared with the three months ended February 28, 2006 primarily as a result of increased costs of directors and officers insurance coverage. Decreases in expenses were recorded for the three months ended February 28, 2007 as compared with the three months ended February 28, 2006 for rent, office supplies, website, marketing, and for sundry expenses in the approximate amounts of $49,000, $7,000, $22,000, $15,000, and $61,000, respectively.

During the three months ended February 28, 2007, the Company recorded $304,000 of settlement and license expense relating to the mediation agreement with Fish. The amount consists of an accrual for February 2007 royalties of approximately $244,000 to be paid by March 31, 2007, the $15,000 payment to Maasai Power and Light and an adjustment of the contingency payable to the actual amount of $3,000,000 due by May 1, 2007 (see Note 8 for more information).

Other income and expenses for the Company for the three months ended February 28, 2007 included equity in the earnings of Phoenix Digital. The investment is accounted for in accordance with the equity method of accounting for investments. The Company’s investment in the joint venture for the three months ended February 28, 2007 provided income after expenses in the amount of approximately $11,657,000 resulting from licensing agreements for our intellectual property with Lexmark, Schneider Electric, NEC Corporation and its selected subsidiaries and Funai Electric for one time payments. The Company’s investment in the joint venture provided net income after expenses in the amount of approximately $29,328,000 for the three months ended February 28, 2006. Total other income and expense for the three months ended February 28, 2007 amounted to net other income of approximately $11,508,000 compared with total other income and expense for the three months ended February 28, 2006 of net other income amounting to approximately $24,040,000. Changes in the fair value of warrant and derivative liabilities amounted to net other expense for the three months ended February 28, 2006 of approximately $4,718,000 with no corresponding amount for the three months ended February 28, 2007 as all convertible debt had been retired in prior fiscal periods. Non-cash adjustments to interest expense for the three months ended February 28, 2006 amounted to expenses of approximately $190,000 resulting from amortization of debt discount and conversion of the remaining debentures. During the three months ended February 28, 2006 the Company recorded a loss on debt extinguishment of $445,000 related to the 7,000,000 warrants issued to a debenture holder as consideration for entering into the reset agreements. Interest income and other income increased from approximately $78,000 for the three months ended February 28, 2006 to approximately $191,000 for the three months ended February 28, 2007 as interest bearing account balances increased from license revenues. During the three months ended February 28, 2007, the Company recorded an impairment charge on the value of its note receivable from Holocom Networks, Inc. of approximately $340,000. (see Note 4 for more information).

The Company recorded net income (as restated) for the three months ended February 28, 2006 of $23,488,416 compared with net income of $9,617,559 for the three months ended February 28, 2007.

Liquidity and Capital Resources

The Company’s cash, marketable securities and short-term investment balances increased from approximately $7,503,000 as of May 31, 2006 to approximately $19,003,000 as of February 28, 2007. We also hold restricted cash in savings accounts amounting to approximately $100,000 as of May 31, 2006 and approximately $102,000 as of February 28, 2007. Total current assets increased from approximately $8,015,000 as of May 31, 2006 to approximately $22,756,000 as of February 28, 2007. Total current liabilities increased from approximately $1,244,000 as of May 31, 2006 to approximately $3,725,000 as of February 28, 2007.

During the nine month periods that ended February 28, 2006 and 2007 the Company generated net cash flows of approximately $12,039,000 and $11,404,000, respectively. However, during recent years we have relied upon financing activities to provide the funds necessary for the Company's operations including sales of common stock, the issuance of convertible debentures and notes payable and related conversions and exercises of common stock warrants. We believe that the Company will be able to avoid such methods of financing operations for the foreseeable future.

During the nine month period ended February 28, 2007 we repurchased 10,779,027 shares of our common stock at an aggregate cost of $7,441,664 through the Company’s stock repurchase program.

We believe the Company's current position as of February 28, 2007 will provide the funds necessary to support the Company's operations for the next 12 months.

A summary of our outstanding contractual obligations at February 28, 2007 is as follows:

Contractual Cash Obligations	Total Amounts Committed		Less than 1 Year		1-3 Years

Operating lease - facilities	$	193,788	$	95,508	$	98,280

Recent Accounting Pronouncements

On June 1, 2006, we adopted Statement of Financial Accounting Standards No. 123 (revised 2004), Share-Based Payment (“SFAS 123(R)”), which requires the measurement and recognition of compensation expense for all share-based payment awards made to our employees and directors based on estimated fair values. We adopted SFAS 123(R) using the modified prospective transition method, which requires the application of the accounting standard as of June 1, 2006, the first day of our fiscal year 2007. Our condensed consolidated financial statements as of and for the nine months ended February 28, 2007 reflect the impact of SFAS 123(R). In accordance with the modified prospective transition method, our condensed consolidated financial statements for prior periods have not been restated to reflect, and do not include, the impact of SFAS 123(R). The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in our condensed consolidated statement of operations. Prior to the adoption of SFAS 123(R), we accounted for stock-based awards to employees and directors using the intrinsic value method in accordance with APB 25 as allowed under Statement of Financial Accounting Standards No. 123, Accounting for Stock-Based Compensation (“SFAS 123”). As stock-based compensation expense recognized in the condensed consolidated statement of operations for the first quarter of fiscal 2007 is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures. SFAS 123(R) requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimated. We estimated forfeitures to be 5% of the options issued.

Stock-based compensation expense recognized under SFAS 123(R) for the nine months ended February 28, 2007 was approximately $2,356,000, determined by the Black-Scholes valuation model, and consisting of stock-based compensation expense related to employee and director stock options and also vesting of options previously granted. See Note 1 to the condensed consolidated financial statements for additional information.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

N/A

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(e) under the Exchange Act, as of February 28, 2007, the end of the period to which this quarterly report relates, we have carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures. This evaluation was carried out under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer.

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our report filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of February 28, 2007, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during our most recently completed fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II- OTHER INFORMATION

Item 1. Legal Proceedings

Patriot Scientific Corporation v. Russell Fish

Lowell Giffhorn Arbitration

Patent Litigation Patent Litigation

Pursuant to the joint venture that the Company entered into in June 2005 with TPL (in settlement of inventorship/ownership litigation between the parties, and in return for a 50-50 sharing of net licensing and enforcement revenues), the Company granted TPL the complete and exclusive right to enforce and license its microprocessor patent portfolio. The Company then dismissed its patent infringement claims against Fujitsu Computer Systems, Inc.; Matsushita Electric Corporation of America; NEC Solutions (America) Inc.; Sony Electronics Inc.; and Toshiba America Inc., and certain related entities of these defendants which had been pending in the Federal District Court for the Northern District of California. Thereafter, TPL, on behalf of the TPL/Patriot joint venture and Patriot, filed patent infringement actions against certain of the foregoing defendants (except Sony) and their related entities in the Federal District Court for the Eastern District of Texas, which litigation is currently pending. Litigation is not currently pending with regard to Fujitsu or NEC and certain of NEC’s subsidiaries as listed below.

Item 1A. Risk Factors

We urge you to carefully consider the following discussion of risks as well as other information contained in this Form 10-Q. The following are what we believe to be all our material risks. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations.

Patriot Has Reported Substantial Revenue In 2006 and 2007 Which May Not Be Indicative Of Our Future Revenue Trends

During fiscal 2006 and the first three quarters of fiscal 2007, the Company entered into license agreements, directly and through our joint venture with Technology Properties Limited, that generated aggregate license revenues of approximately $138,000,000. Because of the uncertain nature of the negotiations that lead to license revenues, we cannot predict the amount of future revenues from such agreements, or whether there will be future revenues from license agreements at all.

Patriot Is Dependent Upon A Joint Venture In Which It Is A Passive Partner For Substantially All Of Its Revenues

In June of 2005, we entered into a joint venture with Technology Properties Limited, pursuant to which Technology Properties Limited is responsible for the licensing and enforcement of Patriot’s microprocessor patent portfolio. This joint venture has been the source of virtually all of Patriot’s revenues since June of 2005. Therefore, in light of the absence of revenue from other sources, Patriot should be regarded as entirely dependent on the success or failure of the licensing and prosecution efforts of Technology Properties Limited on behalf of the joint venture. Sales of our microprocessor products have resulted in limited revenues. Our other product lines are no longer being actively marketed, and also generate only limited and sporadic sales.

Patriot’s Limited Sales And Marketing Capabilities Have Affected Our Revenue

We currently have limited marketing capabilities and may need to hire additional sales and marketing personnel. We may not be able to recruit, train, or retain qualified personnel to sell and market our products and may not be able to develop a successful sales and marketing strategy. We also have very limited marketing experience. Any marketing efforts undertaken by us may not be successful and may not result in any significant sales of our products.

Patriot May Experience Difficulties In The Completion Of Its Development Stage Products

Our technologies and products are in various stages of development. We do not currently have in-house development personnel, nor have we retained independent researchers. Therefore, our development stage products may not be completed on a timely basis or at all. Additionally, even if we do recommence our development activities, our development stage products may not be completed due to the inherent risks of new product and technology development, limitations on financing, competition, obsolescence, the absence or loss of key personnel and other factors. Although we have licensed some of our technology at its current stage of development, we may not continue to be able to do so and any revenues generated from licensing may not be sufficient to support operations at their current level. Also, unanticipated technical obstacles can arise at any time and result in lengthy and costly delays or in a determination that further development is not feasible.

Patriot Has Settled A Legal Dispute Which Could Impact Our Future Results Of Operations And Working Capital Position

We were sued by a co-inventor of the technology underlying our microprocessor patent portfolio with regard to proceeds we received as a consequence of recently signed license agreements. On February 14, 2007, we finalized a settlement of this litigation. This settlement requires us to pay the co-inventor $6,400,000 ($3,400,000 of which has already been paid) and up to $2,000,000 from the proceeds we receive from future licensing transactions. These payments have resulted, and will result, in a reduction of our net income in the current quarter and future quarters until our obligations under the settlement have been fulfilled.

A Successful Challenge To The Proprietary Nature Of Our Intellectual Property Would Have A Significant And Adverse Effect On Us

A successful challenge to our ownership of our technology or the proprietary nature of our intellectual property would materially damage our business prospects. We rely on a combination of patents, trademarks, copyrights, trade secret laws, confidentiality procedures and licensing arrangements to protect our intellectual property rights. We currently have eight U.S. patents, one European patent, and one Japanese patent issued. Any issued patent may be challenged and invalidated. Patents may not issue from any of our pending applications. Any claims allowed from existing or pending patents may not be of sufficient scope or strength to provide significant protection for our products. Patents may not be issued in all countries where our products can be sold so as to provide meaningful protection or any commercial advantage to us. Our competitors may also be able to design around our patents.

Vigorous protection and pursuit of intellectual property rights or positions characterize the fiercely competitive semiconductor industry, which has resulted in significant and often protracted and expensive litigation. Therefore, our competitors and others may assert that our technologies or products infringe on their patents or proprietary rights. Persons we believe are infringing our patents are vigorously defending their actions and have asserted that our patents are invalid. Problems with patents or other rights could increase the cost of our products or delay, preclude new product development and commercialization by us, and limit future license revenue. If infringement claims against us are deemed valid or if our infringement claims are successfully opposed, we may not be able to obtain appropriate licenses on acceptable terms or at all. Litigation could be costly and time-consuming but may be necessary to protect our future patent and/or technology license positions or to defend against infringement claims. We are currently involved in patent litigation in the United States District Court for the Eastern District of Texas (see “Legal Proceedings”). Additionally, re opposing parties in the litigation and one other person have petitioned the Patent and Trademark Office to re examine certain of our patents. An adverse decision in the ligitation or in the re examination process would have a very significant and adverse effect on our business.

If A Large Number Of Patriot Shares Are Sold All At Once Or In Blocks, The Market Price Of Our Shares Would Most Likely Decline

Our warrant holders are not restricted in the price at which they can sell common stock acquired through the exercise of warrants. Shares sold at a price below the current market price at which the common stock is trading may cause the market price to decline. The shares of common stock that are issuable on the exercise of our warrants represent a significant portion of our fully-diluted capitalization.

The Market For Patriot’s Stock Is Subject To Rules Relating To Low-Priced Stock (“Penny Stock”) Which May Limit Our Ability To Raise Capital

Our common stock is currently listed for trading in the NASD Over-The-Counter Bulletin Board Market and is subject to the “penny stock rules” adopted pursuant to Section 15(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). In general, the penny stock rules apply to non-NASDAQ or non-national stock exchange companies whose common stock trades at less than $5.00 per share or which have tangible net worth of less than $5,000,000 ($2,000,000 if the company has been operating for three or more years). Such rules require, among other things, that brokers who trade “penny stock” on behalf of persons other than “established customers” complete certain documentation, make suitability inquiries of investors and provide investors with certain information concerning trading in the security, including a risk disclosure document, quote information, broker’s commission information and rights and remedies available to investors in penny stocks. Many brokers have decided not to trade “penny stock” because of the requirements of the penny stock rules, and as a result, the number of broker-dealers willing to act as market makers in such securities is limited. The “penny stock rules,” therefore, may have an adverse impact on the market for our common stock and may affect our ability to raise additional capital if we decide to do so.

Our Share Price Could Decline As A Result Of Short Sales

The downward pressure on the price of our common stock as our warrant holders exercise their warrants and sell material amounts of common stock could encourage short sales by the warrant holders or others. When an investor sells stock that he does not own, it is known as a short sale. The seller, anticipating that the price of the stock will go down, intends to buy stock to cover his sale at a later date. If the price of the stock goes down, the seller will profit to the extent of the difference between the price at which he originally sold it less his later purchase price. Short sales enable the seller to profit in a down market. Short sales could place significant downward pressure on the price of our common stock.

Our Future Success Depends In Significant Part Upon The Continued Services Of Our Key Senior Management

Our future success depends in significant part upon the continued services of our key senior management personnel. The competition for highly qualified personnel is intense, and we may not be able to retain our key managerial employees or attract and retain additional highly qualified technical and managerial personnel in the future. None of our employees is represented by a labor union, and we consider our relations with our employees to be good. None of our employees is covered by key man life insurance policies.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On April 28, 2006 the Company’s Board of Directors authorized a stock repurchase program. We commenced the program in July 2006 and plan to repurchase outstanding shares of our common stock on the open market from time to time. As part of the program, we purchased 10,779,027 shares of our common stock at an aggregate cost of $7,441,664 during the nine months ended February 28, 2007.

Following is a summary of all repurchases by the Company of its common stock during the nine month period ended February 28, 2007:

Period	Total Number of Shares Purchased		Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
June 1 - 30, 2006		-	$	-		-
July 1 - 31, 2006		2,075,003	$	0.89		2,075,003
August 1 - 31, 2006		-	$	-		-
September 1 - 30, 2006		1,199,824	$	0.78		1,199,824
October 1 - 31, 2006		1,000,000	$	0.80		1,000,000
November 1 - 30, 2006		600,000	$	0.75		600,000
December 1 - 31, 2006		3,041,500	$	0.63		3,041,500
January 1 - 31, 2007		1,923,700	$	0.52		1,923,700
February 1 - 28, 2007		939,000	$	0.55		939,000
Total		10,779,027	$	0.69		10,779,027

Issuance of Common Stock

During the nine months ended February 28, 2007, investors exercised warrants to purchase 272,500 shares of common stock for proceeds of $72,250 and investors exercised warrants of 22,732,380 to purchase 22,459,880 shares of common stock on a cashless basis.

During the nine months ended February 28, 2007, directors exercised stock options to purchase 515,000 shares of common stock for proceeds of $41,750.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Submission of Matters to a Vote of Security Holders

None.

Item 5. Other Information

None.

Item 6. Exhibits

The following Exhibits are filed as part of, or incorporated by reference into, this Report:

Exhibit No.	Document
2.1	Agreement to Exchange Technology for Stock in Patriot Scientific Corporation, incorporated by reference to Exhibit 2.1 to Form 8-K dated August 10, 1989*
2.2	Assets Purchase Agreement and Plan of Reorganization dated June 22, 1994, among the Company, nanoTronics Corporation and Helmut Falk, incorporated by reference to Exhibit 10.4 to Form 8-K dated July 6, 1994*
2.2.1	Amendment to Development Agreement dated April 23, 1996 between the Company and Sierra Systems, incorporated by reference to Exhibit 2.2.1 to Pre-Effective Amendment No. 1 to Registration Statement on Form SB-2 filed April 29, 1996*
2.3	Form of Exchange Offer dated December 4, 1996 between the Company and certain shareholders of Metacomp, Inc. incorporated by reference to Exhibit 2.3 to Form 8-K filed January 9, 1997*
2.4	Letter of Transmittal to Accompany Shares of Common Stock of Metacomp, Inc. Tendered Pursuant to the Exchange Offer Dated December 4, 1996 incorporated by reference to Exhibit 2.4 to Form 8-K filed January 9, 1997*
3.1	Original Articles of incorporation of the Company’s predecessor, Patriot Financial Corporation, incorporated by reference to Exhibit 3.1 to registration statement on Form S-18, file no. 33-23143-FW*
3.2	Articles of Amendment of Patriot Financial Corporation, as filed with the Colorado Secretary of State on July 21, 1988, incorporated by reference to Exhibit 3.2 to registration statement on Form S-18, File No. 33-23143-FW*
3.3	Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on March 24, 1992, incorporated by reference to Exhibit 3.3 to Form 8-K dated May 12, 1992*

Exhibit No.	Document
3.3.1	Certificate of Amendment to the Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on April 18, 1995, incorporated by reference to Exhibit 3.3.1 to Form 10-KSB for the fiscal year ended May 31, 1995*
3.3.2	Certificate of Amendment to the Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on June 24,1997, incorporated by reference to Exhibit 3.3.2 to Form 10-KSB for the fiscal year ended May 31, 1997, filed July 18, 1997*
3.3.3	Certificate of Amendment to the Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on April 28, 2000, incorporated by reference to Exhibit 3.3.3 to Registration Statement on Form S-3 filed May 5, 2000*
3.3.4	Certificate of Amendment to the Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on May 6, 2002, incorporated by reference to Exhibit 3.3.4 to Registration Statement on Form S-3 filed June 27, 2002*
3.3.5	Certificate of Amendment to the Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on October 16, 2003, incorporated by reference to Exhibit 3.3.5 to Registration Statement on Form SB-2 filed May 21, 2004*
3.4	Articles and Certificate of Merger of Patriot Financial Corporation into the Company dated May 1, 1992, with Agreement and Plan of Merger attached thereto as Exhibit A, incorporated by reference to Exhibit 3.4 to Form 8-K dated May 12, 1992*
3.5	Certificate of Merger issued by the Delaware Secretary of State on May 8, 1992, incorporated by reference to Exhibit 3.5 to Form 8-K dated May 12, 1992*
	Certificate of Merger issued by the Colorado Secretary of State on May 12, 1992, incorporated by reference to Exhibit 3.6 to Form 8-K dated May 12, 1992*
3.7	Bylaws of the Company, incorporated by reference to Exhibit 3.7 to Form 8-K dated May 12, 1992*
4.1	Specimen common stock certificate, incorporated by reference to Exhibit 4.1 Form 8-K dated May 12, 1992*
4.2	Form of Stock Purchase Warrant (Labway Corporation) dated February 29, 1996, exercisable to purchase 253,166 common shares at $1.58 per share until August 31, 1996, granted to investors in connection with an offering of securities made in reliance upon Regulation S, incorporated by reference to Exhibit 4.2 to Form 10-QSB for fiscal quarter ended February 29, 1996, filed March 15, 1996*
4.3	Form of 6% Convertible Subordinated Promissory Note due September 30, 1998 aggregating $1,500,000 to six investors incorporated by reference to Exhibit 4.3 to Form 10-QSB for fiscal quarter ended August 31, 1996, filed October 15, 1996*
4.4	Form of 5% Convertible Term Debenture (CC Investments, LDC) due June 2, 1999 aggregating $2,000,000 to two investors incorporated by reference to Exhibit 4.4 to Form 8-K dated June 16, 1997*
4.5	Form of Stock Purchase Warrant (CC Investments, LDC) dated June 2, 1997 exercisable to purchase an aggregate of 400,000 common shares at $1.69125 per share until June 2, 2002, granted to two investors in connection with the offering of securities in Exhibit 4.4 incorporated by reference to Exhibit 4.5 to Form 8-K filed June 17, 1997*
4.6	Registration Rights Agreement dated June 2, 1997 by and among the Company and CC Investments, LDC and the Matthew Fund, N.V. related to the registration of the common stock related to Exhibits 4.4 and 4.5 incorporated by reference to Exhibit 4.6 to Form 8-K filed June 17, 1997*

Exhibit No.	Document
4.7	Form of Warrant to Purchase Common Stock (Swartz Family Partnership, L.P.) dated June 2, 1997 exercisable to purchase an aggregate of 211,733 common shares at $1.69125 per share until June 2, 2002, granted to a group of investors in connection with the offering of securities in Exhibit 4.4 incorporated by reference to Exhibit 4.7 to Form 8-K filed June 17, 1997*
4.8	Registration Rights Agreement dated June 2, 1997 by and among the Company and Swartz Investments, LLC related to the registration of the common stock related to Exhibit 4.7 incorporated by reference to Exhibit 4.8 to Form 8-K filed June 17, 1997*
4.9	Form of 5% Convertible Term Debenture (CC Investments, LDC) due June 2, 1999 aggregating $1,000,000 to two investors incorporated by reference to Exhibit 4.9 to Form 10-KSB for the fiscal year ended May 31, 1998, filed August 19, 1998*
4.10	Form of Stock Purchase Warrant (CC Investments, LDC) dated November 24, 1997 exercisable to purchase an aggregate of 200,000 common shares at $1.50 per share until June 2, 2002, granted to two investors in connection with the offering of securities described in Exhibit 4.9 incorporated by reference to Exhibit 4.10 to Form 10-KSB for the year ended May 31, 1998, filed August 19, 1998*
4.11	Form of Warrant to Purchase Common Stock (Swartz Family Partnership, L.P.) dated November 24, 1997 exercisable to purchase an aggregate of 105,867 common shares at $1.50 per share until June 2, 2002, granted to a group of investors in connection with the offering of securities described in Exhibit 4.9 incorporated by reference to Exhibit 4.11 to Form 10-KSB for the year ended May 31, 1998, filed August 19, 1998*
4.12	Form of Warrant to Purchase Common Stock (Investor Communications Group, Inc.) dated June 16, 1997 exercisable to purchase an aggregate of 130,000 common shares at prices ranging from $2.50 to $7.50 per share until June 15, 1999 incorporated by reference to Exhibit 4.12 to Form 10-KSB for the year ended May 31, 1998, filed August 19, 1998*
4.13	Warrant to Purchase Common Stock issued to Spellcaster Telecommunications, Inc. dated April 28, 1998 exercisable to purchase an aggregate of 100,000 common shares at $1.25 per share until April 28, 2000 incorporated by reference to Exhibit 4.13 to Form 10-KSB for the year ended May 31, 1998, filed August 19, 1998*
4.14	Investment agreement dated February 24, 1999 by and between the Company and Swartz Private Equity, LLC for a maximum aggregate amount of $5,000,000 incorporated by reference to Exhibit 4.14 to Form 10-QSB/A for the fiscal quarter ended November 30, 1998, filed March 5, 1999*
4.15	Registration Rights Agreement dated February 24, 1999 by and between the Company and Swartz Private Equity, LLC related to the registration of the common stock related to Exhibit 4.14 incorporated by reference to Exhibit 4.15 to Form 10-QSB/A for the fiscal quarter ended November 30, 1998, filed March 5, 1999*
4.16	Form of Warrant to Purchase Common Stock (Swartz Private Equity, LLC) dated February 24, 1999 exercisable to purchase common shares in connection with the offering of securities in Exhibit 4.14 incorporated by reference to Exhibit 4.16 to Form 10-QSB/A for the fiscal quarter ended November 30, 1998, filed March 5, 1999*
4.17	Amended and Restated Investment Agreement dated July 12, 1999 by and between the Company and Swartz Private Equity, LLC for a maximum aggregate amount of $5,000,000 incorporated by reference to Exhibit 4.17 to Pre-Effective Amendment No. 2 to Registration Statement on Form SB-2 filed July 15, 1999*
4.18	Investment Agreement dated May 2, 2000 by and between the Company and Swartz Private Equity, LLC for a maximum aggregate amount of $30,000,000 incorporated by reference to Exhibit 4.18 to Registration Statement on Form S-3 filed May 5, 2000*

Exhibit No.	Document
4.18.1	Waiver and Agreement dated September 24, 2001 amending the Investment Agreement (1) dated May 2, 2000 by and between the Company and Swartz Private Equity, LLC for a maximum aggregate amount of $30,000,000 incorporated by reference to Exhibit 4.18.1 to Registration Statement on Form S-1 filed October 11, 2001*
4.19	2001 Stock Option Plan of the Company dated February 21, 2001 incorporated by reference to Exhibit 4.19 to Registration Statement on Form S-8 filed March 26, 2001*
4.20	Investment agreement dated September 17, 2001 by and between the Company and Swartz Private Equity, LLC for a maximum aggregate amount of $25,000,000 incorporated by reference to Exhibit 4.20 to Registration Statement on Form S-1 filed October 11, 2001*
4.21	Registration Rights Agreement dated September 17, 2001 by and between the Company and Swartz Private Equity, LLC related to the registration of the common stock related to Exhibit 4.20 incorporated by reference to Exhibit 4.21 to Registration Statement on Form S-1 filed October 11, 2001*
4.22	Warrant to Purchase Common Stock dated September 17, 2001 exercisable to purchase common shares in connection with the Offering of securities in Exhibit 4.20 incorporated by reference to Exhibit 4.22 to Registration Statement on Form S-1 filed October 11, 2001*
4.23	Financial Consulting Services Agreement between the Company and M. Blaine Riley, Randall Letcavage and Rosemary Nguyen incorporated by reference to Exhibit 4.23 to Registration Statement on Form S-8 filed January 22, 2002*
4.24	Form of 8% Convertible Debenture (Lincoln Ventures, LLC) due June 10, 2004 aggregating $1,000,000 to six investors incorporated by reference to Exhibit 4.24 to Registration Statement on Form S-3 filed June 27, 2002*
4.25	Form of Stock Purchase Warrant (Lincoln Ventures, LLC) dated June 10, 2002 exercisable to purchase an aggregate of 12,859,175 common shares at initial exercise prices ranging from $0.08616 to $0.10289 per share until June 10, 2007, granted to six investors in connection with the offering of securities described in Exhibit 4.24 incorporated by reference to Exhibit 4.25 to Registration Statement on Form S-3 filed June 27, 2002*
4.26	Form of Registration Rights Agreement (Lincoln Ventures, LLC) dated June 10, 2002 by and among the Company and six investors related to the registration of the common stock related to Exhibit 4.24 incorporated by reference to Exhibit 4.26 to Registration Statement on Form S-3 filed June 27, 2002*
4.27	2003 Stock Option Plan of the Company dated July 2, 2003 incorporated by reference to Exhibit 4.27 to Registration Statement on Form S-8 filed September 4, 2003*
4.28	Form of 8% Convertible Debenture, Stock Purchase Warrant, Registration Rights Agreement and Securities Purchase Agreement for financings entered into between September 28, 2004 and January 17, 2005 incorporated by reference to Exhibit 4.28 to Registration Statement on Form SB-2 filed February 2, 2005.*
4.29	Approval Rights Agreement and Termination of Antidilution Agreement and Addendum to Warrants dated October 10, 2006, incorporated by reference to Exhibit 4.29 to Form 10-KSB for the fiscal year ended May 31, 2006*
10.1	1992 Incentive Stock Option Plan of the Company, incorporated by reference to Exhibit 10.1 to Form 8-K dated May 12, 1992*
10.1.1	Amendment to 1992 Incentive Stock Option Plan dated January 11, 1995, incorporated by reference to Exhibit 10.1.1 to Form S-8 filed July 17, 1996*

Exhibit No.	Document
10.2	1992 Non-Statutory Stock Option Plan of the Company, incorporated by reference to Exhibit 10.2 to Form 8-K dated May 12, 1992*
10.2.1	Amendment to 1992 Non-Statutory Stock Option Plan dated January 11, 1995 incorporated by reference to Exhibit 10.2.1 to Form 10-KSB for fiscal year ended May 31, 1996, filed August 16, 1996*
10.3	Lease Agreement between the Company’s subsidiary Metacomp, Inc. and Clar-O-Wood Partnership, a California limited partnership dated April 11, 1991 as amended November 11, 1992 and November 2, 1995 incorporated by reference to Exhibit 10.3 to Form 10-KSB for fiscal year ended May 31, 1997, filed July 18, 1997*
10.4	Stock Purchase Agreement dated November 29 and 30, 1995, between the Company and SEA, Ltd., incorporated by reference to Exhibit 10.4 to Form 8-K filed December 11, 1995*
10.4.1	Letter Amendment to Stock Purchase Agreement dated January 31, 1996, between the Company and SEA, Ltd., incorporated by reference to Exhibit 10.4.1 to Form 10-QSB for fiscal quarter ended February 29, 1996, filed March 15, 1996*
10.5	1995 Employee Stock Compensation Plan of the Company, incorporated by reference to Exhibit 10.5 to Form 10-QSB for fiscal quarter ended November 30, 1995, filed December 28, 1995*
10.6	Letter Stock and Warrant Agreement dated January 10, 1996 between the Company and Robert E. Crawford, Jr., incorporated by reference to Exhibit 10.6 to Form 10-QSB for fiscal quarter ended February 29, 1996, filed March 15, 1996*
10.7	Non-Exclusive Manufacturing and Line of Credit Agreement dated February 28, 1996, between the Company and Labway Corporation, incorporated by reference to Exhibit 10.7 to Form 10-QSB for fiscal quarter ended February 29, 1996, filed March 15, 1996*
10.8	Distribution and Representation Agreement dated February 28, 1996, between the Company and Innoware, Inc., incorporated by reference to Exhibit 10.8 to Form 10-QSB for fiscal quarter ended February 29, 1996, filed March 15, 1996*
10.9	Employment Agreement dated November 20, 1995 between the Company and Elwood G. Norris, incorporated by reference to Exhibit 10.9 to Registration Statement on Form SB-2 filed March 18, 1996*
10.9.1	First Amendment to Employment Agreement dated May 17, 1996 between the Company and Elwood G. Norris, incorporated by reference to Exhibit 10.9.1 to Pre-Effective Amendment No. 2 to Registration Statement on Form SB-2 filed May 23, 1996*
10.10	Employment Agreement dated November 20, 1995 between the Company and Robert Putnam, incorporated by reference to Exhibit 10.10 to Registration Statement on Form SB-2 filed March 18, 1996*
10.11	Sales Contractual Agreement dated March 19, 1996 between the Company and Evolve Software, Inc., incorporated by reference to Exhibit 10.11 to Pre-Effective Amendment No. 1 to Registration Statement on Form SB-2 filed April 29, 1996*
10.11.1	Two Year Stock Purchase Warrant dated March 19, 1996 Granted to Evolve Software, Inc. Providing for the Purchase of up to 50,000 Common Shares at $2.85, incorporated by reference to Exhibit 10.11.1 to Pre-Effective Amendment No. 1 to Registration Statement on Form SB-2 filed April 29, 1996*
10.12	Employment Agreement dated as of May 8, 1996 between the Company and Michael A. Carenzo, including Schedule A - Stock Option Agreement, incorporated by reference to Exhibit 10.12 to Pre-Effective Amendment No. 2 to Registration Statement on Form SB-2 filed May 23, 1996*

Exhibit No.	Document
10.12.1	First Amendment to Employment Agreement dated as of May 8, 1996 between the Company and Michael A. Carenzo dated September 23, 1996, incorporated by reference to Exhibit 10.12.1 to Form 10-KSB for the fiscal year ended May 31, 1997, filed July 18, 1997*
10.13	1996 Stock Option Plan of the Company dated March 25, 1996 and approved by the Shareholders on May 17, 1996, incorporated by reference to Exhibit 10.13 to Pre-Effective Amendment No. 2 to Registration Statement on Form SB-2 filed May 23, 1996*
10.14	Sales Contractual Agreement dated June 20, 1996 between the Company and Compunetics Incorporated incorporated by reference to Exhibit 10.14 to Form 10-KSB for fiscal year ended May 31, 1996, filed August 16, 1996*
10.15	Sales Contractual Agreement dated July 31, 1996 between the Company and Premier Technical Sales, Inc. incorporated by reference to Exhibit 10.15 to Form 10-KSB for fiscal year ended May 31, 1996, filed August 16, 1996*
10.16	Employment Agreement dated January 1, 1997 between the Company and Norman J. Dawson incorporated by reference to Exhibit 10.16 to Form 10-KSB for fiscal year ended May 31, 1997, filed July 18, 1997*
10.17	Employment Agreement dated January 1, 1997 between the Company and Jayanta K. Maitra incorporated by reference to Exhibit 10.17 to Form 10-KSB for fiscal year ended May 31, 1997, filed July 18, 1997*
10.18	Technology License and Distribution Agreement dated June 23, 1997 between the Company and Sun Microsystems, Inc. incorporated by reference to Exhibit 10.18 to Form 10-KSB for the fiscal year ended May 31, 1997, filed July 18, 1997*
10.19	Employment Agreement dated March 23, 1999 between the Company and James T. Lunney incorporated by reference to Exhibit 10.19 to Form 10-KSB for the fiscal year ended May 31, 1998, filed August 19, 1998*
10.20	Employment Agreement dated July 28, 1997 between the Company and Phillip Morettini incorporated by reference to Exhibit 10.20 to Form 10-KSB for the fiscal year ended May 31, 1998, filed August 19, 1998*
10.21	Employment Agreement dated July 23, 1998 between the Company and Lowell W. Giffhorn incorporated by reference to Exhibit 10.21 to Form 10-KSB for the fiscal year ended May 31, 1998, filed August 19, 1998*
10.22	Secured Promissory Note dated June 12, 2000 between the Company and James T. Lunney incorporated by reference to Exhibit 10.22 to Form 10-KSB for the fiscal year ended May 31, 2000, filed August 29, 2000*
10.23	Purchase Agreement dated June 29, 2000 between the Company and 4S 37/38, LLC incorporated by reference to Exhibit 10.23 to Form 10-KSB for the fiscal year ended May 31, 2000*
10.24	Employment Agreement dated October 2, 2000 between the Company and Miklos B. Korodi incorporated by reference to Exhibit 10.24 to Form 10-QSB for the fiscal quarter ended November 30, 2000, filed January 12, 2001*
10.25	Employment Agreement dated December 1, 2000 between the Company and Richard G. Blum incorporated by reference to Exhibit 10.25 to Form 10-QSB for the fiscal quarter ended November 30, 2000, filed January 12, 2001*

Exhibit No.	Document
10.26	Employment Agreement dated January 29, 2001 between the Company and Serge J. Miller incorporated by reference to Exhibit 10.26 to Form 10-KSB for the fiscal year ended May 31, 2001, filed August 29, 2001*
10.27	Lease Agreement dated February 23, 2001 between the Company and Arden Realty Finance IV, LLC incorporated by reference to Exhibit 10.27 to Form 10-KSB for the fiscal year ended May 31, 2001, filed August 29, 2001*
10.28	Employment Agreement dated January 1, 2001 between the Company and David H. Pohl incorporated by reference to Exhibit 10.28 to Form 10-KSB for the fiscal year ended May 31, 2001, filed August 29, 2001*
10.29	Employment Agreement dated April 26, 2001 between the Company and David H. Pohl incorporated by reference to Exhibit 10.29 to Form 10-KSB for the fiscal year ended May 31, 2001, filed August 29, 2001*
10.30	Employment Agreement dated November 17, 2001 between the Company and Lowell W. Giffhorn incorporated by reference to Exhibit 10.30 to Registration Statement on Form S-3 filed June 27, 2002*
10.31	Employment Agreement dated December 20, 2001 between the Company and Jayanta Maitra incorporated by reference to Exhibit 10.31 to Registration Statement on Form S-3 filed June 27, 2002*
10.32	Consulting Agreement dated March 7, 2002 between the Company and SDMC, Inc. incorporated by reference to Exhibit 10.32 to Registration Statement on Form S-3 filed June 27, 2002*
10.33	Employment Agreement dated January 2, 2004 between the Company and Jayanta Maitra incorporated by reference to Exhibit 10.33 to Registration statement on Form SB-2 filed May 21, 2004*
10.34	Consulting Agreement dated March 18, 2004 between the Company and SDMC, Inc. incorporated by reference to Exhibit 10.34 to Registration Statement en Form SB-2 filed May 21, 2004*
10.35	Employment Agreement dated June 1, 2004 between the Company and Patrick Nunally incorporated by reference to Exhibit 10.35 to Form 10-KSB for the fiscal year ended May 31, 2004, filed August 19, 2004*
10.36	Amendment No. 1 to Employment Agreement dated July 12, 2004 between the Company and Patrick Nunally incorporated by reference to Exhibit 10.36 to Form 10-KSB for the fiscal year ended May 31, 2004, filed August 19, 2004*
10.37	Employment Agreement dated September 1, 2004 between the Company and Lowell W. Giffhorn incorporated by reference to Exhibit 10.37 to Registration Statement on Form SB-2 filed February 2, 2005*
10.38	IGNITE License Agreement with Advanced Micro Devices, Inc., dated February 21, 2005, incorporated by reference to Exhibit 10.38 to Form 10-KSB for the fiscal year ended May 31, 2006*
10.39	Patent Portfolio License Agreement with Advanced Micro Devices, Inc., dated February 21, 2005, incorporated by reference to Exhibit 10.39 to Form 10-KSB for the fiscal year ended May 31, 2006*
10.40	Master Agreement, dated as of June 7, 2005, by and among the Company, Technology Properties Limited Inc., a California corporation and Charles H. Moore, an individual, incorporated by reference to Exhibit 10.40 to Form 8-K filed June 15, 2005*
10.41	Commercialization Agreement dated as of June 7, 2005 by and among the JV LLC, Technology Properties Limited Inc., a California corporation, and the Company, incorporated by reference to Exhibit 10.41 to Form 8-K filed June 15, 2005*

Exhibit No.	Document
10.42	Limited Liability Company Operating Agreement of JV LLC, a Delaware limited liability company, dated as of June 7, 2005, incorporated by reference to Exhibit 10.42 to Form 8-K filed June 15, 2005*
10.43	Agreement for Part-Time Employment dated August 3, 2005 between the Company and Thomas J. Sweeney, incorporated by reference to Exhibit 99.3 to Form 8-K filed August 9, 2005*
14.1	Code of Ethics for Senior Financial Officers incorporated by reference to Exhibit 14.1 to Form 10-K for the fiscal year ended May 31, 2003, filed August 29, 2003*
31.1	Certification of David H. Pohl, CEO, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**
31.2	Certification of Thomas J. Sweeney, CFO, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**
32.1	Certification of David H. Pohl, CEO, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
32.2	Certification of Thomas J. Sweeney, CFO, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
99.1	Form of ISO Plan Option (Gaspar) dated May 29, 1992, incorporated by reference to Exhibit 28.2 to registration statement on Form SB-2, file no. 33-57858*
99.2	Form of NSO Plan Option (Berlin) dated May 29, 1992, incorporated by reference to Exhibit 28.3 to registration statement on Form SB-2, file no. 33-57858*
99.3	Form of Incentive Stock Option Agreement to the Company’s 1996 stock Option Plan (individual agreements differ as to number of shares, dates, prices and vesting), incorporated by reference to Pre-Effective Amendment No. 2 to Registration Statement on Form SB-2 filed May 23, 1996*
99.4	Form of Non-Qualified Stock Option Agreement to the Company’s 1996 Stock Option Plan (individual agreement differ as to number of shares, date, prices and vesting), incorporated by reference to Pre-Effective Amendment No. 2 to Registration Statement on Form SB-2 filed May 23, 1996*
99.5	Press Release of the Company dated November 4, 1996 incorporated by reference to Exhibit 99.5 to Form 8-K filed January 9, 1997*
99.6	Form of Incentive Stock Option Agreement to the Company’s 2001 Stock Option Plan incorporated by reference to Exhibit 99.6 to Registration Statement on Form S-8 filed March 26, 2001*
99.7	Form of Non-Qualified Stock Option Agreement to the Company’s 2001 Stock Option Plan incorporated by reference to Exhibit 99.7 to Registration Statement on Form S-8 filed March 26, 2001*
99.8	Form of Incentive Stock Option Agreement to the Company’s 2003 Stock Option Plan incorporated by reference to Exhibit 99.8 to Registration Statement on Form S-8 filed September 4, 2003*
99.9	Form of Non-Qualified Stock Option Agreement to the Company’s 2003 Stock Option Plan incorporated by reference to Exhibit 99.9 to Registration Statement on Form S-8 filed September 4, 2003*
*	Previously filed in indicated registration statement or report.
**	Exhibit filed herewith this Quarterly Report on Form 10-Q for the quarterly period ended November 30, 2006.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DATED: April 20, 2007

PATRIOT SCIENTIFIC CORPORATION

/S/ DAVID H. POHL

David H. Pohl

Chief Executive Officer

In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature	Title	Date

/S/ DAVID H. POHL
David H. Pohl	President, Chief Executive Officer, and Director	April 20, 2007


/S/ THOMAS J. SWEENEY	Chief Financial Officer and Principal Accounting Officer	April 20, 2007
Thomas J. Sweeney


/S/ CARLTON M. JOHNSON	Director	April 20, 2007
Carlton M. Johnson


/S/ GLORIA H. FELCYN
Gloria H. Felcyn	Director	April 20, 2007



Helmut Falk, Jr.	Director	April 20, 2007



James L. Turley	Director	April 20, 2007